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สาขาวิชา  ชีวเคม ี
ปการศึกษา  2550 
 
บทคัดยอ 
 
     Transthyretin (TTR) เปนโปรตีนที่ทาํหนาที่ขนสงฮอรโมนไธรอยดและวติามนิเอ 
โดยจับกับ retinal binding protein (RBP) โปรตีนชนิดนี้พบในพลาสมาของสัตวมีกระดูกสันหลัง
หลายชนิด ซ่ึงในคน TTR มีแหลงสรางที่สําคัญ 2 แหลงคือ ตับและ choroid plexus ในสมอง จาก
การศึกษาพบวาในระหวางวิวัฒนาการของสัตวมีกระดกูสันหลังชั้นต่าํจนมาถึงสัตวเลี้ยงลูกดวยนม
น้ัน พบวาความสามารถในการเขาจับของ TTR กับ thyroxine (T4) เพ่ิมขึ้น และในขณะเดียวกัน
จะจับกับ triiodothyronine (T3) ลดลง นอกจากนี้ปลายอะมิโนของ TTR จะสั้นลงและมีความชอบ
นํ้ามากขึ้น และปลายคารบอกซิลของ TTR จะมีความชอบน้ํามากขึ้นเชนกัน และยังพบอีกวา
ปลายคารบอกซิลของ TTR ในสิ่งมีชีวติบางชนิด มีความยาวของลําดับกรดอะมิโนมากกวา TTR 
ในสิ่งมีชีวติชนิดอ่ืน นอกจากนี้ปลายอะมิโนและปลายคารบอกซิลของ TTR มีตําแหนงอยูใกลกับ
บริเวณตําแหนงจับสําหรับฮอรโมนไธรอยด ดังน้ันจึงนําไปสูสมมติฐานทีว่าถามีการเปลี่ยนแปลง
โครงสรางของปลายอะมิโนและ/หรือปลายคารบอกซิลของ TTR นาจะมีผลตอการเขาจับของ TTR 
กับฮอรโมนไธรอยดและการจับกับ ligand อ่ืนๆ 
 
                    การจะสามารถศึกษาถึงอิทธิพลของโครงสรางปลายอะมิโนและปลายคารบอกซิล
ตอหนาที่ของ TTR น้ัน จําเปนตองทําการสังเคราะห chimeric TTR ที่ถูกเปลีย่นแปลงลําดบั
กรดอะมิโน ณ บริเวณทีต่องการศึกษา (hu/croc/pig TTR) และเชือ่มตอเขากับเวคเตอร pPIC 9 
จากนั้นนําเขาสูเซลลยีสตสายพันธุ Pich ia  pas to r i s  เพ่ือใหผลิต recomb inan t  p ro te in          
ออกมา ภายใตการควบคุมของ AOX1 promoter ของยีสต จากการศึกษาพบวา การสังเคราะห 
recombinant TTR ในเซลล Pichia สามารถหลั่งโปรตีนออกมานอกเซลลสูอาหารเลี้ยงเชื้อได
สูงสุดหลังจากกระตุนดวยเมธานอลที่ความเขมขน 1% เปนเวลา 3 วัน โดยจะมีปริมาณโปรตีน
ทั้งหมด 50 มิลลิกรัมตอ1 ลติรของอาหารเลี้ยงเชื้อ นอกจากนี้ recombinant TTR ที่ไดสามารถทํา
บริสุทธิไ์ดเพียงขั้นตอนเดียวโดยวธิี preparative native gel electrophoresis อยางไรก็ตาม
ปริมาณโปรตีนที่ไดจากการทําบริสุทธิ์ เทากับ 1 มิลลกิรัมตอ 1 ลิตรของอาหารเลี้ยงเชื้อ และจาก
การศึกษาคุณสมบัติทางเคมีกายภาพของ recombinant TTR ที่ผลิตได พบวามีคุณสมบัติคลาย 
iv
กับ TTR ในสิ่งมีชีวิตชนดิอ่ืน โดยที่ recombinant TTR ที่ไดมีคุณสมบัติในการเคลื่อนที่ใน
กระแสไฟฟาภายใตสภาวะธรรมชาติ ไดเร็วกวาอัลบมิูนในพลาสมาของคน ในการวิเคราะหหา
นํ้าหนักโมเลกุลโดยวิธ ี HPLC พบวา recombinant TTR ที่ไดมีนํ้าหนักโมเลกุลเทากับ 58,884 
daltons สวนการหาน้ําหนักโมเลกุลของหนวยยอยของ recombinant TTR ที่ไดโดย SDS-PAGE 
พบวามีนํ้าหนกัเทากับ 15,488 daltons นอกจากนี้จากการศึกษาโดยวิธี western blotting พบวา 
recombinant TTR สามารถจับอยางจําเพาะกับแอนตบิอดีตอ Crocodylus porosus TTR และยัง
มีความสามารถในการจับอยางจําเพาะกับ RBP จากการศึกษายังแสดงใหเห็นวาการเปลี่ยนแปลง
ปลายอะมิโนและปลายคารบอกซิลของ TTR มีผลตอการเพิ่ม molar ratio ของการจับกันระหวาง 
TTR กับ RBP  
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ABSTRACT 
 
Transthyretin (TTR) is one of the major thyroid hormone binding 
proteins found in plasma of higher vertebrates and plays role in metabolism of retinol 
via its binding to the retinol binding protein (RBP). In human, TTR is mainly 
synthesized in liver and choroid plexus of the brain. During evolution of mammalian 
TTR from its ancestor, the binding affinity to T4 increased while that to T3 decreased, 
the N-terminal region of TTR is shorter and more hydrophilic, and C-terminal region is 
more hydrophilic and some are longer. Together with the fact that these N-and           
C-termini locate at the entrance of thyroid hormone binding site, it prompted to an 
assumption that changes in structure of N-terminal segment and/or C-terminal segment 
of the TTR subunit affect the accession of thyroid hormones and also other ligands to 
the binding site of the TTR molecule.  
 
In order to examine the influence of the primary structure of the 
terminal regions on biological function of TTR, the cDNA coding for chimeric 
hu/croc/pigTTR was constructed and cloned into the pPIC9 expression vector. The 
cDNA was induced to express under the AOX1 promoter in a methylotrophic yeast 
P. pastoris. The result showed that the recombinant hu/croc/pigTTR was successfully 
synthesized and extracellularly secreted into the yeast culture medium. The synthesis 
reached maximum after induction with 1% methanol for 3 days at 50 mg per liter of 
culture. The TTR can be purified in a single step by preparative native gel 
electrophoresis, however, at 1 mg per liter of culture. The purified TTR showed 
physicochemical properties similar to other TTRs found in nature. Under native 
condition, the TTR showed the electrophoresis mobility faster than human albumin. By 
HPLC, it revealed that TTR formed tetramer and molecular weight of the tetramer was 
vi
58,884 daltons, and by SDS-PAGE, the mass of the TTR subunit was 15,488 daltons. 
In addition, the recombinant TTR showed cross reactivity with the antibody against    
C. porosus TTR and had specific binding to human RBP. Changes in N-and               
C-terminal regions of the TTR increased the molar ratio of the binding to RBP. 
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CHAPTER 1 
 
INTRODUCTION 
 
Introduction 
 
Thyroid hormones have a wide range of biological effects on 
numerous vertebrate species. Their major roles involve in growth, development and 
regulation of metabolism of the vertebrates (Brent, 1994). There are several forms of 
thyroid hormones, but two major forms that are important for biological activity are 
L-3,5,3′,5′-tetraiodothyronine (L-thyroxine, T4) and L-3,5,3′-triiodothyronine         
(L-triiodothyronine, T3). T4 functions as prohormone and exists in blood circulation 
as a major product of thyroid grand, while, T3 is the biologically active form and its 
significant amount is obtained from the conversion of T4 by 5′-deiodinase in 
peripheral tissue (Surk et al., 1973; Samuels et al., 1989 and Greenspan, 1994). The 
action and metabolism of thyroid hormones occur in the intracellular compartment. 
According to highly hydrophobic phenyl structure of thyroid hormones, they are 
transported in blood stream as a complex with plasma proteins. This prevents the 
partitioning into lipid membranes of thyroid hormones and maintains the appropriate 
distribution of the hormones between extracellular aqueous and lipid environment 
(for review see Schreiber and Richardson, 1997). 
 
Transthyretin (TTR) is one of the three major thyroid hormone binding 
proteins found in blood of larger mammalian. In human, it is mainly synthesized in 
liver and choroid plexus of the brain. TTR is a homotetrameric protein of which each 
subunit has a molecular mass of the 14 kDa (Blake et al., 1978). In human, the TTR 
subunit consists of 127 amino acid residues (Kanda et al., 1974). The functional 
tetramer of TTR contains two binding sites that differ in relative binding affinity for 
thyroid hormones (Kanda et al., 1974). However, under physiological conditions, 
only one binding site is found occupied by thyroid hormones (Pages et al., 1973 and 
Nilsson et al., 1975). Binding affinity of TTR to thyroid hormones varied among 
 
              1
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vertebrate species. The affinity to T4 increased while that to T3 decreased during the 
evolution of mammalian TTR from its ancestor (Chang et al., 1999). 
 
 The structural analysis of TTR genes from numerous vertebrate 
species revealed that the amino acid sequences in the central channel with thyroid 
hormones binding site is highly conserved. Predominant changes occurred within first 
ten amino acids from N-terminal end and seven amino acids from C-terminal end. 
During evolution of vertebrates, N-terminal region of TTR is longer and more 
hydrophobic in avian, reptilian, amphibian and fish than in mammalian. Similar 
variation also occurred at C-terminal region of TTR, leading to more hydrophobicity 
of the region in amphibian and fish than in mammalian. In addition, the C-terminal 
segment of some TTRs, i.e. from pig, Xenopus laevis and bullfrog, is longer than that 
of TTRs from other animal species. Due to the changes in length and hydrophathy 
occurred at N-terminal and C-terminal regions, and due to the fact that these            
N-terminus and C-terminus of TTR locate at the entrance of thyroid hormone binding 
site, it prompted to an assumption that changes in structure of N-terminal segment 
and/or C-terminal segment of the TTR subunit affect the accession of thyroid 
hormones as well as other ligands to the binding site of the TTR molecule. 
 
Apart from transporting of thyroid hormones, transportation of retinol 
binding protein (RBP) is another important function of TTR. Complex formation of 
TTR with RBP, the specific carrier of retinol (an alcohol form of vitamin A), has 
been suggested to prevent loss of vitamin A from glomerular filtration in kidney 
(Peterson, 1971). Binding of TTR and RBP molecule was shown involved with the 
hydrophobic interaction. The study by X-ray crystallography revealed that several 
amino acids are involved in the intermolecular contact of TTR-RBP molecule (Naylor 
and Newcomer., 1999), and amino acid substitution at some positions found in TTR 
variant, e.g. substitution of isoleucine to serine in TTR Ile84Ser, brought to reduction 
of binding affinity to RBP of TTR (Berni et al., 1994).  
 
Currently, interaction between TTR and amyloid proteins has been 
reported. Inhibition on fibril formation of amyloid β-protein as well as a proteolytic 
activity on apoA-I, a variant of apolipoprotein A (Liz et al., 2004), of TTR has been 
revealed in human. This finding led to an assumption on a possible relationship 
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between TTR and amyloid proteins in physiological as well as pathological 
conditions. Although proteolytic activity of TTR has been clarified as a serine 
protease (Liz et al., 2004), amino acid residues involved in catalysis are still unknown. 
 
To elucidate the role of N and/ or C-terminal segment on the 
biological functions of TTR including the proteolytic property and ability in binding 
to ligands, the chimeric TTRs of which N- and/or C-terminal sequence is properly 
altered is necessary. In this thesis, cDNA of a chimeric C. porosus TTR was 
constructed, the recombinant chimeric TTR was synthesized using the heterologous 
protein expression system of Pichia pastoris and properties of the TTR were 
determined.  
 
Review of Literatures  
1.  Thyroid hormone 
 1.1  Structure and synthesis site of thyroid hormone 
Thyroid hormones are involved in the regulation of growth, 
differentiation, and metabolism in vertebrate. The major forms of thyroid hormones 
synthesized and secreted by thyroid gland into the bloodstream of vertebrates with 
significant biological activity are L-3,5,3′,5′-tetraiodothyronine (L-thyroxine, T4) and 
L-3,5,3′-triiodothyronine (L-triiodothyronine, T3) (Samuels et al., 1988). The 
molecule of thyroid hormone can be divided into there regions: a hydrophobic          
4′-hydroxyl group, two phenyl rings that are linked together by an ether bond with an 
angle of 120 degree, and the amino acid side chain on the tyrosine ring (Figure 1.1) 
(Ribeiro et al., 1998 and Samuels et al., 1988). The major form of thyroid hormone 
secreted by thyroid gland is thyroxine (T4). Within target cell, T4 is converted to T3 
by outer ring deiodination (for reviews see Kohrle et al., 2002 and Richardson et al., 
2005). T3 has higher affinity for thyroid hormone receptors (TR) than T4 (Sandler     
et al., 2004 and Richardson et al., 2005) and appears to be more potent in thyroid 
hormone action than T4. Thus, T3 can be considered to be the major active form of 
thyroid hormones in target tissues (Gross et al., 1952; Lerman, 1953; Surk and 
Oppenheimer, 1997). 
 4
 1.2  Distribution of TH     
Thyroid hormone action and metabolism occur in the intracellular 
compartment. In brain, thyroid hormones in the bloodstream must cross the blood 
brain barrier to reach the brain (Seibert and Nelson, 1942). However, because the 
thyroid hormone is a typical extracellular hydrophobic signaling molecule, to be able 
to mediate transferring of information from outside cells by permeation through 
membranes, the hormone requires an extracellular thyroid hormone binding protein 
system (Schreiber, 2002). In the bloodstream of vertebrates, there are three thyroid 
hormone distributors, thyroxine binding globulin (TBG), TTR and albumin (Larsson 
et al. 1985). In human TBG has the highest affinity for thyroid hormones, while TTR 
has intermediate affinity and albumin has the lowest affinity (Robbins and Edelhoch, 
1986). In lower vertebrates such as reptile, amphibian and fish, albumin is proposed 
to be a major carrier for thyroid hormones in the blood stream (Richardson et al., 
1994). 
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Figure 1.1   Structure of thyroid hormones (from Yen, 2001) 
 
 
 
 
 
 
 
3, 5, 3′, 5′-Tetraiodothyronine (thyroxine, T4) 
3, 5, 3′-triiodothyronine (T3) 
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1.3  Role of TH in vertebrate    
Thyroid hormone is known playing an important role in development, 
metabolism and homeostasis in vertebrate (Morreale de Escobar et al., 1987; Tata, 
1999; Silva, 2001; and Yen, 2001). It also has the effects on metamorphosis as well 
as development and differentiation of specific organs of reptilian (Chiu and Lam, 
1994), fish (Miwa et al., 1988) and the parr-smolt transformation (smoltification) of 
migratory salmonids (Hoar, 1939). In human, various pathological stages and 
developmental abnormalities result from inadequate or excessive levels of circulating 
thyroid hormones. These include mental retardation, stunted growth, hearing loss and 
alterations in thermogenic homeostasis and heart rate (Norman and Lavin, 1989 and 
Lim et al., 2002). During amphibian metamorphosis, activation of thyroid gland 
resulted in elevating of circulating thyroid hormones have been observed (Etkin, 
1965; Regadr et al., 1978; Suzuki and Suzuki, 1981). In many vertebrate species, the 
same raising of thyroid hormone levels in blood crucial stages of thyroid hormone-
dependent development (Hulbert, 2000). 
 
2.  Transthyretin 
 2.1  Structure of transthyretin 
Transthyretin (TTR) is homotetrameric protein with a molecular mass 
of ∼55 kDa (Branch et al., 1971 and Blake et al., 1978). In human, each subunit of 
TTR is composed of 127 amino acids with mass of 13,745 daltons, leading to 
molecular mass of the entire molecule is 54,980 daltons (Kanda et al., 1974). The 
tetramer of TTR is organized from two dimers. A monomer is arranged into two of 
four-stranded β-sheets. Dimers of TTR are then formed by edge-to-edge interaction 
of two monomers resulting in a pair of twisted eight-stranded β-sheets. Association of 
two dimers by dimer-dimer contacts resulted in a tetramer structure with a large 
solvent channel passing through the molecule in which two sterically equivalent 
thyroid hormone binding sites exist (Naylor and Newcomer, 1999). Although a 
molecule of TTR provided two binding sites for thyroid hormone, only one site was 
occupied under physiological condition (Pages et al., 1973 and Nillsson et al., 1975). 
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The X-ray crystallography analysis revealed that human TTR has a 
very high β-sheet content with only a small length of a helix. Each TTR subunit 
consists two of four-β strands (DAGH and CBEF) that are antiparallel to each other. 
Nearly all residues are involved in the β-strands or the loops connecting them, or in 
the short helix. Only ten N-terminal and five C-terminal residues do not appear to be 
involved in the folding but merely exist as a ‘head’ and ‘tail’ (Blake et al., 1978). The 
interaction between monomers that forms a stable dimer is predominantly involved 
with hydrogen bonding between the β-strands at the edges of two monomers (strands 
F and H) (Blake et al., 1978). To form the tetramer, two dimers interact through the 
hydrophobic contact involving residues that situated in AB and GH-loops. The 
thyroxine-binding sites are situated in one large hydrophobic channel that is formed 
between two dimers at the tetramer interface (Figure 1.2) (Wojtcak et al., 1996). The 
unusual high content of β-structure, the interaction between monomers to form 
dimers and dimers to form tetramer contribute to formation and make TTR to be the 
most stable globular protein (Branch et al., 1971 and 1972). However, in comparing, 
the TTR tetramer was less stable than the dimer (Blake et al., 1978). 
 
A large central channel with two sterically equivalent thyroid hormone 
binding sites that differ in their relative binding affinity is formed in consequence of 
tetrahedral arrangement of the TTR subunits (Blake et al., 1978). These two identical 
funnel-shaped thyroxine binding sites are found located deeply in the central pocket 
connected by a very narrow channel centered (Figure 1.3) (Green et al., 2003). The 
negative cooperativity of hormone binding implies that only one molecule of 
thyroxine binds TTR tetramer (Blake et al., 1978). 
 
The TTR tetramer is less stable than the dimer (Blake et al., 1978). 
However, the tetramer does not dissociate in strong acidic or alkaline or even in   
0.1% sodium dodecyl sulfate (SDS) solution. Dissociation of the tetramer occurred 
slowly in 6 M guanidinium chloride at pH 5.9 (Branch et al., 1972). In the presence 
of 1% SDS and 10 mM β-mercaptoethanol, at least 80% of human TTR tetramer was 
still intact after boiling for less than 20s (Bellovino et al., 1998). Loses in binding 
activity to thyroid hormone of TTR evidenced when TTR was treated with 6 M urea, 
however, it was restored after removing out urea (Raz and Goodman, 1969). 
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Figure 1.2   Structure of TTR tetramer 
  The extended inner β-sheet (DAGHH′G′A′D′) is shown in blue, the 
 outer (CBEFF′E′B′C′) in red. The helix is yellow, and the loops, 
 which contribute to the formation of TTR tetramer, are in green 
 (modified from Hamilton and Benson, 2001) 
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 2.2  Sites of TTR syntheis and secretion 
Hepatocyte is the major site of TTR synthesis and its secretion into 
blood (Dickson et al., 1982). The synthesis site in liver is confirmed by the presence 
of large amounts of TTR mRNA detected by in situ hybridization (Dickson et al., 
1985 and Jacobsson, 1988). In addition, TTR is the protein that found most 
abundantly synthesized by choroid plexus, which secreted the TTR into cerebrospinal 
fluid (CSF) (Palha et al., 2002). The concentration ratio of TTR compared to that of 
albumin and other plasma proteins is much higher in CSF than in the blood. High 
concentration of TTR in the CSF suggested to a major role for TTR in mediating T4 
transfer across the blood-choroid-plexus-CSF barrier from blood into brain 
(Schreiber, 2002). In addition, epithelium of the choroid plexus (for review see 
Bartalena, 1990; Dickson et al., 1986 and Stauder et al., 1986;) and ependymal cells 
of the subcommissural organ in brain (Montecinos et al., 2005) were also shown to be 
a strong synthesis site of TTR. Besides, TTR mRNA was also localized, though with 
much less extent, by immuno-reactivity and in situ hybridization in several other 
tissues, including endocrine cells of stomach, small intestine and colon (Gray et al., 
1985 and Liddle et al., 1985), retinal pigment epithelium of eye (Martone et al., 1988; 
Herbert et al., 1986; Cavallaro et al., 1990; Dwork et al., 1990; Mizuno et al., 1992; 
Ong et al., 1994 and Jaworowski et al., 1995), kidney (Katoh et al., 1982 and Kato   
et al., 1984), and visceral extraembryonic endoderm and foregut endoderm (Makover 
et al., 1989). In fetus, it demonstrated a synthesis site of TTR in placental tissue 
(McKinnon et al., 2005). 
 2.3  Function of TTR 
 2.3.1  Thyroid hormone distributor   
The widely known main biological function of TTR is transport of 
thyroid hormones in both T4 and T3 forms (Robbins, 1996). The tetramer of TTR 
contains a central channel with two binding sites for thyroid hormones (Figure 1.3) 
(Blake et al. 1978). However, only one binding sites of TTR is occupied by thyroid 
hormone (Pages et al., 1973 and Nilsson et al., 1975), due to negative cooperativity 
(Wojtczak et al., 1996). In human, 10-15% of T4 in serum and up to 80% of the 
hormone in central nervous system are transported by TTR. The TTR that is 
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synthesized in the choroid plexus epithelial cells is secreted into CSF (for review see 
Schreiber et al., 1990), and in the CSF, the majority of T4 binds to TTR (Hagen and 
Solberg, 1974). However, some TTR in the CSF may not bind T4 at all near the 
choroid plexus and T4 is also likely to permeate through the blood–brain barrier away 
from the ventricular region. This TTR, therefore, participate in equilibration between 
free and TTR-bound T4 (for review see Schreiber, 2002). 
 
The binding characteristic of TTR to thyroid hormones was changed 
during evolution of vertebrates (for reviews see Schieber and Richardson, 1997 and 
Scheiber et al., 1999). Binding of human TTR to T4 was stronger than T3 whereas 
TTR from fish, amphibians, reptiles and birds binds T3 better than T4 (Pages et al., 
1973; Chang et al., 1999 and Prapunpoj et al., 2000a, 2002). 
 
 2.3.2  Carrier of retinol via binding to RBP 
 TTR is also known as a retinol or vitamin A carrier by which through 
interaction with the plasma RBP (Raz et al., 1970). The binding of TTR to RBP was 
suggested to prevent the loss of small RBP as well as vitamin A molecule from 
glomerular filtration in kidney (Peterson, 1971). It was also shown that the formation 
of RBP and TTR complex stabilized the binding between retinal and RBP (Goodman, 
1974 and Raz et al., 1970). By crystallography experiment, it revealed that two 
molecules of RBP bind to one TTR tetramer (Figure 1.4) (Rask et al., 1971 and 
Hörnberg, 2004). In addition, binding of T4 and RBP to the same TTR molecule was 
independent and did not show any effect on each other. 
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Figure 1.3   The thyroid hormone binding sites in TTR molecule  
The thyroid hormone is shown in the two possible binding pockets 
between the dimers, although there is negative co-operativity of binding 
for the two positions (modified from Hamilton and Benson, 2001). 
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Figure 1.4   The TTR-RBP complex  
Two molecules of RBP bind to the TTR tetramer (from Hörnberg, 
2004). 
 
RBP 
RBP 
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 2.4.  Evolution of structure and function of TTR 
 
Comparison of the primary structure of TTR from several animal 
species revealed the conservation during evolution of vertebrates of amino acids in 
core of the subunit and in the central channel with the thyroid hormone binding sites 
of TTR (Chang et al., 1999; Schreiber et al., 1998; Hamilton et al., 1993; for reviews 
see Schreiber Richardson, 1997 and Schreiber et al., 1998 ). Alteration of the primary 
structure of the TTR N- terminus occurred predominantly with in the first ten amino 
acids that protrude out from the TTR molecule and are located near the entrance to 
the central channel of TTR (Schreiber et al., 1998 and Hamilton et al., 1993). During 
the evolution of mammalian TTRs from TTR ancestors, the affinity to T4 increased 
while the affinity to T3 decreased, i.e. TTR from fish, amphibians, reptiles and birds 
binds T3 with higher affinity, whereas TTR from mammals binds T4 with higher 
affinity (Chang et al., 1999; for review see Scheiber et al., 1999 and Prapunpoj et al., 
2000a, 2002). The nucleotide triplets encoding for Val-Ser-His at position 4-6 from 
the N-terminus is lost in eutherians compared with birds and reptiles (Duan et al., 
1991, 1995a and Achen et al., 1993) (Figure 1.5), leading to increase in hydrophilic 
of the N-terminal of the eutherian TTR subunit (Duan et al., 1995a). In other word, 
the N-terminal segment of the TTR subunit is longer and more hydrophobic in avian 
and reptilian than in eutherian. X. laevis TTR has an even longer and more 
hydrophobic N-terminal region than avian and reptilian TTRs (Figure 1.5) (Prapunpoj 
et al., 2000b). The stepwise shifted of mRNA splicing has been proposed to be a 
mechanism of the evolutionary change (Aldred et al., 1997; for reviews see Schreiber 
and Richardson, 1997 and Schreiber et al., 1998). Changes in the N-terminal region 
e.g. longer and more hydrophobic N-termini of TTR, have been suggested to affect 
the accessibility of the thyroxine-binding site in the central channel of TTR (Duan    
et al., 1995a). Comparative analysis of thyroid hormones binding affinity of 
recombinant crocodile TTRs supported the influence of the N-terminal segment on 
binding affinity to T4 and T3 (Prapunpoj et al., 2002).  
 Variation in amino acid sequence of TTRs during evolution of 
vertebrates also observed at C-terminal segment. The C-termini of TTRs from pig and 
bullfrog have more amino acid residues than that from other vertebrates (Figure 1.6). 
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In addition, hydropathy of the C-terminal sequence was more hydrophobic in 
reptilian, amphibian and fish TTRs than in mammalian TTR. The X-ray 
crystallography analysis of TTR tetramer showed that not only N- but also C-terminal 
region locates at the entrance to the central channel that harbors the thyroid hormones 
binding site (Black et al., 1978). Therefore, changing the amino acid residues at      
N- and/or C-terminal regions possibly affect the accession of thyroid hormones and 
other ligands to the binding site that locates inside of the TTR molecule. 
To date, 100 point mutations in TTR gene have been identified and up 
to 80 of these mutations were demonstrated related to amyloidosis, a group of protein 
folding disease in which normal or mutate form of proteins aggregate into insoluble 
fibril and deposit in extracellular space of organs/tissues leading to dysfunction and 
death of the organs and tissues. The mechanism of self-assembly to a fibrillar 
structure of these soluble proteins is still unclear. Proteolysis has been proposed to be 
a key regulator of the process. Several evidences have been reported to an 
involvement of proteolytic enzymes in both activation of amyloid fibril formation and 
clearance of the fibrils (Hemming and Selkoe, 2005; for reviews see Selkoe, 2004; 
Russo et al., 2005 and Higuchi et al., 2005). Co-localization of TTR with 
amyloidogenic apolipoprotein A-I (apoA-I) was first identified in kindred with   
apoA-I amyloidosis (Sousa et al., 2000). Thereafter, proteolytic cleavage of             
C-terminus of apoA-I by TTR was revealed as a cryptic nature and TTR triggering 
the fibril formation of apoA-I was proposed. However, the canonical catalytic triad 
could not be identified (Liz et al., 2004). The proteolytic activity of TTR can be 
inhibited by serine and chymotrypsin-like serine protease inhibitors, and it has a 
cleavage preference for a Phe residue on P1. Therefore, TTR was suggested to be a 
cryptic chymotrypsin-like serine protease (for review see Liz and Sousa, 2005). To 
understand the role of TTR proteolysis in amyloidoses, its catalytic site needed to be 
identified. Role of TTR in catabolism of amyloid β-protein (Aβ), which is a main 
component of amyloid plaques in Alzheimer’s disease, has been suggested in many 
reports (Schwarzman  et al., 1994; Mazur-Kolecka et al., 1995 and Link, 1995). TTR 
was found formed complexes with Aβ and inhibited aggregation and fibril formation 
of the amyloid protein in vitro and in vivo (Golabek et al., 1995; Tsuzuki et al., 1997 
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and Mazur-Kolecka et al., 1997). However, relationships between TTR and this 
amyloid protein remain unclear. Studying pathogenic relationship between 
amyloidogenic processes could only suggest that amyloidogenic mutation in TTR 
might affect the interaction of TTR with Aβ in which lead to the inability of 
aggregated TTR proteins to prevent Aβ polymerization (Schwarzman et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 16
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17
Figure 1.5   Comparison of the nucleotide and derived amino acid sequences of 
TTR precursor at the exon 1/intron 1 (A) and intron 1/exon 2 (B) 
borders with those from other vertebrate species 
The nucleotide sequences in exons are in bold upper case, while those in 
introns are in lower case. The deduced amino acid sequences are given 
beneath the nucleotide sequences. The consensus recognition sequences 
for splicing are indicated in bold above the positions of the splice sites in 
human TTR mRNA. The amino acid sequence of the N-terminus, 
determined by Edman degradation of the mature or the recombinant 
TTRs, are indicated by a box open at the right end (modified from 
Prapunpoj et al., 2002; for details see Prapunpoj et al., 2002). 
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Figure 1.6   Comparative alignment of structure of vertebrate TTRs  
Amino acid sequence or that derived from the cDNA sequence of 
vertebrate TTRs are aligned with the amino acid sequences of human 
TTR. Single-letter amino acid abbreviations are used. X indicates an 
amino acid could not be unambiguously identified by Edman 
degradation. Asterisks are residues identical to those in human TTR. 
Gaps were introduced for proper alignment. Features of secondary 
structure of human TTR are indicated above the sequences. Numbering 
of residues is based on that for human TTR. Negative numbers indicate 
the residues in the presegment; positive numbers represent residues of 
the mature protein. Negative Greek letters α, β, δ, γ, and ε were 
introduced to indicate positions of residues in non-eutherian species. 
Bold letters indicate the first amino acid of mature TTRs. Double 
underlining indicates amino acid residues located in the central channel. 
Gray shading indicates amino acid residues, in the central channel, that 
are involved in binding thyroid hormones (from Prapunpoj et al., 2002). 
Extra amino acid residues found in TTRs from pig, bullfrog and            
X. laevis are in boxes. 
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3.  Recombinant protein synthesis systems 
 3.1  General        
Two general categories of expression systems are prokaryotic and 
eukaryotic systems. In general, the prokaryotic systems are easier to handle and 
satisfactory for most purposes. However, there are serious limitations in using 
prokaryotic cells for the production of eukaryotic proteins. There is no universal 
expression system for heterologous proteins. All expression systems have some 
advantages as well as some disadvantages that should be considered in selecting 
which one is best for the target protein. Choosing the best one requires evaluating the 
options from yield to glycosylation and to proper folding (Rai and Padh, 2001).         
In comparison with bacteria, eukaryotes, in particular yeast, have a number of 
advantages as hosts for heterologous protein production. The eukaryotic cell system 
has an intrinsic ability in express, process and folds the protein correctly. Particular 
post-translational modifications such as glycosylation that may be required for the in 
vivo biological function of the protein (Dube et al., 1988; Han and Martinage, 1992; 
Claffey et al., 1995; Hooker and James, 1998), immunogenic properties, and other 
features of authentic eukaryotic proteins related to the three-dimensional structure can 
be obtained by the eukaryotic cell systems. Among eukaryotic cells, heterologous 
expression in Pichia pastoris, which is the methylotrophic yeast, has many of the 
advantages of eukaryotic expression (Cregg et al., 1985; Cregg et al., 1993; Higgins 
and Cregg, 1998). More than 100 foreign proteins form bacteria, fungi, plants, 
invertebrates, vertebrates (includes humans) have been expressed in P. pastoris. The 
yield of recombinant proteins from P. pastoris depends critically on growth 
conditions. Using high cell densities in fermentation has been shown to improve 
protein yields by 10 to 100 folds. When grown on methanol, the foreign proteins 
secreted from P. pastoris can represent 80% or more of the total protein in the culture 
medium (Tschopp et al., 1987a). The recent developments of the P. pastoris 
expression system have had an impact on not only the expression levels can be 
achieved, but also the bioactivity of various heterologous proteins (Macauley et al., 
2005). 
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Use of heterologous expression systems for synthesis in large amount 
of proteins has allowed to determine both biochemical and structural parameters of 
many different enzymes. However, because several different organisms have been 
adapted for the recombinant protein expression, the choice of which system to use 
will depend upon the characteristics of the protein itself, the yield required for, and 
subsequent ease of purification (Morton and Potter, 2000 ). For recombinant TTR, the 
synthesis in large amount has been reported using two expression systems i.e. E. coli 
and P. pastoris.  
 
3.2  Bacterial expression  system                                                   
 The bacterial expression systems, especially in E. coli, is by far the 
most widely employed host for that post-translational modifications of the product are 
not essential. E. coli has high growth rates and can express high level of heterologous 
proteins. Furthermore, it can grow rapidly to high density in such simple and 
inexpensive media. Strains that are used for recombinant production have been 
genetically manipulated so that they are generally regarded as safe (GRAS) for     
large-scale fermentation. However, several disadvantages of bacterial expression 
systems have been reported. The system poses significant problems in                  
post-translational modifications of proteins. Common bacterial expression systems in 
particular E. coli have no capacity to glycosylate proteins in either N- or O-linked 
conformation. Although other bacterial strains such as Neisseria meningirulls have 
recently been shown to O-glycosylate some of their endogenous proteins, the 
trisaccharide added is different from the O-linked sugars found in eukaryotes 
(Marston and Hartley, 1990). Synthesis of recombinant human TTR (both wild-type 
and variants) has been reported successfully by using E. coli system and with 
different expression vectors. Wild-type TTR was reported synthesized by using 
pCZ11, a thermo-inducible bacterial expression vector (Murrell et al., 1992), and 
pQE30 (Matsubara et al., 2003). By using the pQE30, TTR was expressed under 
control of a lipoprotein promoter. TTR Met30 variants were synthesized as a fusion 
protein by using the pIN-III-ompA-1 vector. The recombinant protein was               
co-translated with an E. coli outer membrane protein, proteinA (Furuya et al., 1989). 
Other TTR variants, i.e. Gly6Ser, Leu55His, Thr60Ala, Ile84Ser and Ala109Thr, 
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were also produced by using pCZ11 (Murrell et al., 1992). In all cases, the 
recombinant TTRs were reported forming a tetramer with molecular size similar to 
that of human TTR in nature and having ability in binding to thyroxine (Furuya et al., 
1989; Murrell et al., 1992 and Mutsubara  et al., 2003). In addition, the recombinant 
TTR variants showed the same characteristics in amyloid formation at acidic pH as 
the isolated TTR variants (Mutsubara et al., 2003). 
 
3.3  Expression system of TTR in yeast                                
 P. pastoris belongs to the methanol-assimilating yeasts (Lee and 
Komagata, 1980). Growth on methanol of Pichia induces expression of genes whose 
products are required for metabolism of the yeast. Three of enzymes involved in the 
methanol pathway are located in the organelle called peroxisome. As a result, both 
the enzymes that are involved in methanol pathway and the proteins that are involved 
in peroxisome biogenesis (KEX proteins) are induced in response to methanol. The 
most highly regulated among these genes is AOX1 that coding for alcohol oxidase 
(AOX), which is a hydrogen peroxide-producing oxidase working in peroxisome and 
is the first enzyme of the methanol pathway (for review see Lin-Cereghino et al., 
2006). The promoter of AOX1 gene, which is induced by methanol but repressed by 
many carbon sources such as glucose, glycerol and ethanol (Lin-Cereghino et al., 
2006), is widely used to drive the expression of the heterologous genes in the Pichia 
system. Accordingly, methanol is often used as the carbon source to induce the 
production of the heterologous proteins. Besides of induction, shifting of the carbon 
source to methanol was reported causes major structural and physiological changes 
within the cell. The enzymes for methanol metabolism are synthesized de novo and 
some of them are translocated into peroxisomes (Sauer et al., 2004). The methanol 
metabolism pathway in P. pastoris, similarly to that in other methylotrophic yeasts 
(Veenhuis et al., 1983), begins with the oxidation of methanol to formaldehyde by the 
enzyme AOX. Because AOX has a poor affinity for oxygen, yeast synthesizes large 
amount of the enzyme to overcome the low specific activity of the enzyme. 
Biochemical and physiological researches have shown that under methanol induction, 
up to 30% of the cellular proteins is AOX (van Dijken et al., 1976; Couderc and 
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Barratti, 1980; Veenhuis et al., 1983 and Giuseppin et al., 1988). There are two genes 
that code for AOX, AOX1 and AOX2. However, in comparison, AOX1 has stronger 
promoter and is responsible for the majority of the AOX activity in yeast cell       
(Cregg et al., 1989). Expression of the AOX1 gene is tightly regulated and induced by 
methanol at the transcriptional level (Cregg et al., 1985; Ellis et al., 1985 and           
Cregg et al., 1989). Most genes of interest are placed and expressed under control of 
the AOX1 promoter. The heterologous proteins expressed in P. pastoris, can remain 
intracellular after their synthesis or they can be secreted into the medium outside. 
However, secretion of foreign proteins is more popular because it facilitate for 
downstream processing in particular purification of the foreign protein product from 
proteins and other contaminants from the yeast cell. Pichia strain GS115 (his4) is the 
most commonly used as host for the heterologous proteins expression. This wild-type 
strain contains the AOX1 and AOX2 genes, however, it grows on methanol at         
wild-type rate (Mut+) because its growth on methanol mainly relies on the presence of 
the AOX1 gene. 
 More than 100 foreign proteins from bacteria, fungi, plants, 
invertebrates, vertebrates (includes humans) have been expressed in P. pastoris. 
These successful protein gene expressions include TTRs from human (Prapunpoj      
et al., 2006), amphibian (Prapunpoj et al., 2000a) and reptile (Prapunpoj et al., 2002).  
As in other yeast systems, the production of foreign proteins in P. pastoris occurs in 
simple minimal defined media. This makes the system a choice for NMR analysis of 
proteins. 
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Objectives   
      
1.  To construct cDNA of the chimeric TTR in which its N-and/or C-terminal region   
(s), and use the expression system of P. pastoris for synthesis of the recombinant 
chimeric protein. 
2.  To purify and determine general physicochemical properties of the recombinant 
 chimeric TTR. 
3.  To examine the binding to RBP of the chimeric TTR. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
1. Materials 
 1.1 Instruments 
 
Instruments    Model    Company  
Autoclave    ES-315   Tomy 
Balance (4 digits)   AB204-S   Mettler 
Balance (2 digits)   PG5002-S   Mettler 
Centrifuge    Aanti J-30 I   Beckman 
Centrifuge    J2-21    Beckman 
Centrifuge    5804R    Eppendorf 
Centrifuge    Harrier 18/8 (MSE)  SANYO 
Fraction collector   2110    Bio-Rad 
Gel Document (Labworks 4.0) C-80    UVP 
Horizontal Electrophoresis  B1    Owl Scientific 
Incubator        Memmert 
Microcentrifuge   260D    DENVILLE 
Micropipette        Gilson, Labnet, 
         Labmate,  
         Nichipet EX 
Oven     240 litre   Binder 
Orbital shaking incubator      GallenKamp 
         SANYO 
Orbital shaker    SH 30    FINEPCR 
Orbital shaker    MS-OR   Major Science 
pH meter    713    Metrohm 
Power supply    ELITE 300 plus  Wealtec 
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Instrument    Model    Company 
Power supply    PowerPac 3000  Bio-Rad  
Preparative gel electrophoresis  PrepCell 491   Bio-Rad 
Slab gel electrophoresis  AE-6450   ATTO 
Slab gel electrophoresis  Mini Protean 3 cell  Bio-Rad 
Slab gel electrophoresis  mini Protean-II  Bio-Rad 
Spectrophotometer   8453    Hewlett-   
         Packard 
Spectrophotometer   G20    Thermo 
Stirrer         Corning 
Vortex-mixer    VX 100   Labnet 
Water Bath    WB-710M   Optima 
 
 1.2  Chemicals 
 1.2.1  Analytical grade 
 
Chemical        Company 
Absolute ethanol       Normapur 
Acetic acid        Lab Scan 
Acrylamide        Fluka 
Agar         Merck 
Argento nitrate (Silver Nitrate)     Merck 
Biotin         Fluka 
Bis-acrylamide       Fluka 
Boric acid        Merck 
Bovine serum albumin      Sigma 
Calcium chloride       Merck 
Coomassie brilliant blue G-250     Bio-Rad 
Coomassie brilliant blue R-250     Bio-Rad 
D-glucose        Univar 
Di-potassium hydrogen phosphate     J.T. Baker 
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Chemical        Company 
Dithiothreitol        Bio-Rad 
Ethylene diamine tetraacetic acid (EDTA)    Carlo 
Glycerol        Univar 
Glycine        Fisher 
Methanol        Lab Scan 
Peptone        Merck 
Potassium dihydrogen phosphate     Fisher 
Sodium carbonate       Merck 
Sodium chloride       Lab Scan 
Sodium dodecyl sulfate (SDS)     Finechem 
Sorbitol        Sigma 
Tris (Hydoxymethyl)- methylamine     USB 
Tryptone        Merck 
Yeast extract        Merck 
Yeast nitrogen base       Difco 
 
 1.2.2  Molecular biology grade 
 
Chemial        Company 
Agarose        GenePure 
Ampicillin        Calbiochem 
100 bp DNA ladder       New England 
         Biolabs (NEB) 
EcoRI         NEB 
Ethidium bromide       Promega 
pGEM-T Easy vector       Promega 
XhoI         NEB  
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1.2.3  Reagent kits 
 
Reagent        Company 
QIA kit for plasmid purification     QIAGEN 
QIA kit for PCR purification      QIAGEN 
QIA kit for gel extraction      QIAGEN 
 
 1.3  Yeast and Bacterial cells 
  Pichia pastoris strain GS115 is a product of Invitrogen. E. coli DH5α 
is a gift from Professor Schreiber, Australia.  
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2.  Methods 
 
 2.1  Construction of chimeric cDNA and cloning into pGEM Teasy vector  
 
Crocodylus porosus TTR cDNA was used as a template to generate by 
PCR a cDNA coding for the chimeric C. porosus TTR (hu/croc/pig TTR) in which its 
N- and C-terminal regions are replaced by that of human TTR and pig TTR, 
respectively, and the compatible restriction ends (XhoI at 5′ end and EcoRI at 3′ end) 
were introduced to the cDNA for ligation into the Pichia expression vector, pPIC 9. 
The PCR amplification was performed as previous described (Prapunpoj et al., 2002). 
In brief, 50 ng of C. porosus TTR cDNA in an E. coli plasmid was amplified in the 
presence of 40 pmol of the specific primers (Table 1) in 100 μl of the reaction 
mixture. The amplification was started with an initial denaturation step at 94°C for     
5 min. Then, it was followed by 25 cycles of denaturation at 94°C for 30s, annealing 
at 53 °C for 30s and extension at 72°C for 1 min. The final extension was carried out 
at 72°C for 5 min. The PCR product was checked on 1% agarose gel containing       
0.4 μg/ml ethidium bromide for a single band with an expected size, and the reaction 
mixture was purified using the PCR purification kit (QIAGEN). The in vivo 
amplification of the chimeric TTR cDNA in bacterial cell was carried on by ligation 
of the purified cDNA into pGEM Teasy (Promega) with T4 DNA ligase. The ligation 
reaction mixture (10μl in total volume) was comprised of 20 ng of the DNA, 50 ng of 
pGEM Teasy vector, and 3 Weiss units of T4 DNA ligase. 
 
 2.2 Amplification and preparation of the expression vector for 
transformations into Pichia pastoris 
 
The purified TTR cDNA inserted pGEM Teasy vector was 
transformed in to Escherichia coli strain DH5α with a standard protocol and the        
E. coli cells were grown overnight at 37°C. Thereafter, three to five single white 
colonies, which are expected containing the DNA inserted plasmid, were selected and 
colonies were grown in 2 ml of Luria-Bertani (LB) medium containing 100 μg/ml 
ampicillin for overnight at 37°C. The plasmid was purified using the plasmid 
purification kit (QIAGEN), and size of the DNA insert was checked by double 
 30
digestion of the plasmid with XhoI and EcoRI at 37°C for 2 h prior being purified by 
QIAquick Gel Extraction kit (QIAGEN) as described in 2.14. Ligation of the 
chimeric TTR cDNA into pPIC9, which was previously double digested with XhoI 
and EcoRI, was carried out with T4 DNA ligase at 4°C overnight. Thereafter, the 
hu/croc/pigTTR cDNA in pPIC9 was transformed into E. coli for an in vivo 
amplification of the plasmids. The DNA plasmid was purified, and the insertion 
direction of the DNA in the plasmid was determined by DNA sequencing, using 
5′AOX1 primer (5′-GACTGGTTCCAATTGACAAGC-3′). The TTR inserted 
plasmid was, then, linearlized by digestion with SalI at 37°C for 2 h and purified 
using QIAquick PCR purification kit (QIAGEN) prior to being transformed into 
Pichia cells. 
 
 2.3 Transformation of the expression vector into P. pastoris 
 
To prepare the yeast competent cell for electroporation, a single 
colony of Pichia GS115 from fresh yeast extract peptone dextrose (YPD) agar plate 
was grown in 5 ml of YPD medium in a 50-ml tube at 30oC for overnight.             
One hundred microliters of the overnight culture was inoculated in 120 ml of        
YPD medium in a 1-liter flask and grown overnight at 30°C to an OD600 of 1 to 1.6. 
Then, cells were collected by centrifugation at 2,000 rpm for 5 min at 4 oC and 
resuspended with 45 ml of ice-colded distilled water. Cells were collected and 
resuspended once more with 22.5 ml of ice-colded distilled water. Thereafter, cells 
were resuspended with 1.8 ml of ice-colded 1 M sorbitol and finally resuspended in 
0.135 ml of ice-colded sorbitol give a final volume of approximately 0.2 ml. 
 
Transformation of the SalI linearized chimeric TTR cDNA plasmid 
into Pichia competent cells strain GS115 was carried out by an electroporation using 
Gene Pulser (Bio-Rad) and followed the protocol recommend by the company. In 
brief, an aliquot (80 μl) of the competent Pichia cells was mixed with 1.5 μg of the 
linearized plasmid, then transferred the cell mixture to an ice-cold 0.2 cm 
electroporation cuvette. The electroporation was carried out at 1.5 kV, 25 µF and    
400 Ω, generating pulse lengths of ∼9.4 milliseconds with a field strength            
~1.37 kV/cm. Then, the cell suspension was flushed with 1 ml of ice-cold                  
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1 M sorbitol, and all of the mixture was spreaded onto the minimal dextrose medium 
(MD) agar plate and incubated at 30oC for 3 days. 
 
 2.4  Screening for His+Mut+ transformant 
 
 Pichia transformants with phenotype His+Mut+ (histidine synthesis 
and methanol utilization plus) were selected form His+Muts (histidine synthesis and 
methanol utilization slow) by growing the transformants on two selective agar media, 
minimal dextrose medium (MD) and minimal methanol medium (MM). A single 
colony of His+ transformant from a the original MD plate was picked with a sterile 
toothpick, patched onto MM and subsequently onto MD plate. Plates were incubated 
at 30°C for 2 to 3 days. Growth of the His+Mut+, but not His+Muts, is similar on both 
MM and MD. Screening was performed with 150 to 200 His+ transformants and       
up to 50 single colonies of the His+Mut+ transformants were selected for synthesis of 
the recombinant protein. 
 
 2.5  Synthesis of recombinant TTR 
 2.5.1  Small scale synthesis 
 
The Pichia transformants were grown and first induced for synthesis 
of the recombinant TTRs in small scale. In brief, a single colony of Pichia clone, is 
usually on yeast extract peptone dextrose (YPD) plate, was inoculated into 5 ml of 
medium containing glycerol (BMGY). Cells were grown at 30°C in an               
orbital-shaking incubator (200 rpm) until OD600 reaches 2 to 6. Then, cells were 
collected by centrifugation at 2,500 rpm for 5 min at room temperature and 
transferred to grow in 5 ml of the medium containing methanol (BMMY) to an OD600 
around 1.0. Methanol was added every 24 h to maintain level of methanol in the 
culture to 0.5% for 3 days. After induction, the culture supernatant was collected by 
centrifugation at 5,000 rpm for 5 min and kept at -20°C until used. The yeast culture 
supernatant was analyzed for secreted proteins by SDS-PAGE and/or native-PAGE 
and the protein band was detected by silver staining.  
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 2.5.1.1  Optimization of methanol concentration for the induction 
 
The Pichia clone that provides the highest production of the chimeric 
TTR was selected, and optimization was performed for the synthesis of the clone in  
large scale. The optimization was attempted at 0.5% and 1% of methanol 
concentration. 
 
2.5.1.2  Optimization of cell density in culture 
 
 Optimization of cell density, the induction with methanol was carried 
out at 1% of methanol with density of the Pichia cells in culture equivalent to            
2 or 4 units of OD600. The induction was carried on for 3 days, and the culture 
supernatant was analyzed by native-PAGE. 
  
 2.5.2  Large scale synthesis 
 
 Large scale preparation of the chimeric TTR was performed by using 
the shaking flask culture method and the culturing condition described for the small 
scale synthesis was adopted. A single colony of the Pichia clone from YPD plate was 
inoculated into 10 ml of BMGY and the yeast cell was grown at 30°C for 16-18 h. 
Five milliliters of the overnight culture was transferred into 300 ml of BMGY in a     
1-liter flask, and cells were grown until OD600 reached 2 to 6. Then, cells were 
collected by centrifugation at 2,500 rpm for 5 min at room temperature, resuspended 
in 300 ml of BMMY in a 2-liter flask to a density of 4.0 (at OD600). Cells were grown 
at 28oC and induced with methanol for 3 days. Methanol was added to the culture 
every 24 h to maintain the final concentration to 1% thoroughly the induction period. 
Thereafter, the culture supernatant was collected by centrifugation at 5,000 rpm for 
10 min at 4oC. Level of synthesis and secretion into culture medium of the 
recombinant chimeric TTR was determined by native-PAGE and SDS-PAGE 
followed by silver staining. 
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 2.6  Purification of the recombinant TTR 
 
In the Pichia expression system, the recombinant chimeric TTR was 
synthesized and secreted into the medium, facilitating in downstream processing of 
the protein. The recombinant chimeric TTR was purified from the Pichia culture 
supernatant by preparative native-PAGE using Prep Cell 491 (Bio-Rad). The 
discontinuous gel (12% and 4% for resolving and stacking gels, respectively) was 
selected for the separation and the electrophoresis condition was performed according 
to the instruction manual of the company. The Pichia culture supernatant was 
concentrated by ultrafiltration, then the concentrated solution was centrifuged at 
10,000 rpm for 10 min prior loading onto a gel tube. After separartion, protein bands 
were eluted with 50 mM Tris-HCl, pH 7.4 and collected at flow rate of 1 ml/min,      
2 ml/fraction. Proteins in fractions were analyzed by native-PAGE and detected by 
silver staining. The fractions containing TTR were pooled, concentrated and stored    
at -20oC for further analysis. 
 
 2.7 Determination of physicochemical properties of the recombinant TTR 
 
General physicochemical properties of the recombinant chimeric TTR 
including molecular weight (indicating tetramer formation of the TTR), mass of the 
monomer, and electrophoretic mobility were examined to confirm the proper 
structure and folding of the synthesized TTR. 
 
2.7.1  Determination of molecular weight 
 
Molecular weight of the recombinant TTR was estimated by 
HPLC/gel-permeation chromatography on BioSil SEC 250 column (Bio-Rad), 
equilibrated in 0.2 M sodium phosphate buffer pH 6.0. Aliquot of the purified 
chimeric TTR (50 μg) was loaded onto the column and separation was conducted at 
flow rate of 0.4 ml/min. The chromatogram was followed up from the absorbance at 
280 nm. The column was calibrated with blue dextran (2,000 kDa), aldolase          
(158 kDa), bovine serum albumin (68 kDa), ovalbumin (43 kDa), and 
chymotrypsinogen A (25 kD). 
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 2.7.2  Determination of the subunit mass 
 
Subunit mass of the recombinant TTR was determined by SDS-PAGE 
according to the method of Laemmli and Favre (1973). The purified TTR was 
incubated with a solution containing 2% of sodium dodecyl sulphate (SDS) and    
2.5% of β-mercaptoethanol at 100oC for 30 min before loading on                       
SDS-polyacrylamide gel (15% resolving gel and 4% stacking gel) and the 
electrophoresis separation was performed at constant voltage (100 volts). The protein 
band was detected by staining gel with Coomassie brilliant blue R-250. 
 
 2.8  Determination of binding to RBP 
 
To determine the binding property to RBP, the purified recombinant 
chimeric TTR was mixed and incubated with purified human RBP at 4°C for 1 h. 
Thereafter, the reaction mixture was analyzed on 10% native-PAGE, electro-blot 
transferred to a nitrocellulose or PVDF membrane, and the TTR-RBP complex was 
immunochemically detected using the anti-crocodile TTR antibody. 
 
 2.9  Purification of human TTR from plasma 
 
Human TTR that used as a control was purified from plasma in 3 steps, 
affinity chromatography on Cibacon blue column, electrophoresis in a preparative 
native polyacrylamide gel, and electrophoresis in urea gel. 
 
In the first step, human plasma was centrifuged at 10,000 rpm for       
20 min to remove any non-dissolved particles prior to loading onto the Cibacon blue 
column which previously equilibrated with 50 mM phosphate buffer, pH 7.4 (PB) at 
flow rate of 10 ml/h. Unbound proteins were collected and column was washed with 
PB. Thereafter, bound proteins were eluted with PBS. Both bound and unbound 
fractions were analyzed by native-PAGE. The fractions containing TTR were pooled 
and concentrated by ultrafiltration. 
 
In the second step, the concentrated pooled TTR fraction from the first 
step was loaded onto a preparative gel column (12% resolving gel and 4% stacking 
gel). After separation, protein bands were eluted with 50 mM Tris-HCl, pH 7.4, and 
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the eluting fractions were collected at flow rate of 1 ml/min, 2 ml/fraction. Each 
fraction was analyzed for proteins by native-PAGE and the protein bands were 
visualized by silver staining. The fractions containing TTR were pooled and 
concentrated by ultrafiltration.  
 
In the final step, the concentrated pooled TTR fraction from the 
second step was loaded onto a preparative urea gel (12% polyacrylamide gel 
containing 6M urea). The separation was carried out in Tris-Boric-EDTA buffer,     
pH 8.3 (TBE), using the Prep Cell model 491 (Bio-Rad). Proteins were separated and 
eluted at flow rate of 1 ml/min. TTR in fractions was analyzed by native-PAGE and 
detected by silver staining. The fractions containing TTR were pooled, concentrated, 
and stored at -20oC (for use as a control). 
 
2.10 Western blot analysis 
 
 Separation by SDS-PAGE or native-PAGE of protein was preformed 
in duplicate. Then, the protein was electro-transferred to nitrocellulose or PVDF 
membrane, using the transfer buffer containing 25 mM Tris, 192 mM glycine and 
20% (v/v) methanol, pH 8.3, for 1 h at 4°C. Protein bands on the membrane were 
visualized by staining with 0.1% Amido black. Specific proteins were detected by 
immunochemistry, using enzymatic detection. Firstly, non specific binding sites on 
the membrane were blocked by incubation, with gentle shaking, in the blocking 
solution containing 5% skim milk, 25 mM Tris, pH 7.4, 0.15 M NaCl and             
0.1% Tween 20 at room temperature for 1 h. Thereafter, the membrane was incubated 
with primary antibody (antiserum against C. porosus TTR raised in rabbit), diluted in 
blocking agent (1:500), for 1 h at room temperature. The membrane was, then, 
washed once for 15 min and three times for 5 min with 25 mM Tris buffer pH 7.4 
containing 0.15 mM NaCl and 0.1% Tween 20 (TBS-T) at room temperature. After 
washing, the membrane was incubated with secondary antibody (horseradish 
peroxidase (HRP)-linkd anti-rabbit immunoglobulins, raised in donkey) at dilution 
1:2,500 for 1 h at room temperature. Then, the membrane was washed once for         
15 min and three times for 5 min with TBS-T at room temperature. To detect the TTR, 
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activity of the HRP was followed by ECL and the chemiluminescence’s signal was 
detected and analyzed by the Bio-Chemi System (UVP). 
 
  2.11 Preparation of competent cell and transformation of DNA 
 2.11.1 E. coli competent cell 
 
The competent cells were prepared from E. coli strain DH5α using 
calcium chloride as described by Cohen et al. (1992). A single colony from fresh     
LB agar plate was inoculated into 5 ml of LB broth in a 50-ml tube and grown 
overnight at 37°C in an orbital shaking incubator (150 rpm). Then, 50 μl of the 
overnight culture was transferred to 25 ml of LB broth and cells were grown until the 
OD600 reached 0.4 to 0.5 (took 2 to 3 h). Then, cells were cooled down to 0oC           
by storing on ice for 10 min and collected by centrifugation at 2,500 rpm for 10 min 
at 4oC. The supernatant was removed and tube was inverted for 1 to 2 min to drain 
any trace of medium. Cell pellets were resuspended in 4 ml of ice-cold                     
0.1 M calcium chloride and cooled down to 0°C. After centrifugation and draining, 
cells were resuspended in 0.8 ml of ice-cold 0.1 M calcium chloride. Thereafter, the 
competent cells were aliquot (100 μl) and 60% glycerol was added to the final 
concentration of 15.5% (v/v). Immediately, cells were frozen in liquid nitrogen and 
stored at -80°C as a glycerol stock. 
 
To transform cDNA plasmid, 50 µl of the E. coli competent cell 
suspension was mixed with 5 μl of the cDNA plasmid in a polypropylene tube and 
stored on ice for 10 min. Then, the cell mixture was subjected to heat-shock for 
exactly 90 seconds at 42oC without shaking and cooled down to 0oC for 1 to 2 min. 
Thereafter, 100 µl of SOC was added and the mixture was incubated at 37oC for 1 h 
prior to plating onto LB agar plate, in the presence of X-gal (250 µg/10 ml agar) and 
ampicillin (100 µg/ml agar). Cells were allowed to grow at 37°C for 16-18 h. 
 
 2.11.2  Pichia competent cell 
 
To prepare the competent cell, a single colony of P. pastoris strain 
GS115 from yeast extract peptone dextrose (YPD) agar plate was inoculated in           
5 ml of YPD broth at 30oC, overnight. Then, 100 μl of the overnight culture was 
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transferred into 120 ml of fresh YPD medium in a 1-liter flask and continuously 
grown to an OD600 of 1 to 1.6. Cells were collected by centrifugation at 2,000 rpm for 
5 min, at 4oC, and the cell pellet was resuspended in 45 ml of ice-cold sterile       
distilled water. Cells were collected by centrifugation and resuspended once in       
22.5 ml of the ice-cold distilled water. Thereafter, cells were resuspended in 1.8ml of 
ice-cold 1.0 M sorbitol, and finally resuspended in 0.135 ml of the ice-cold sorbitol. 
The competent cells were aliquot, kept at -80oC or immediately used in 
transformation.  
 
To transform the DNA of interest into the Pichia competent cells, an 
aliquot (80µl) of the Pichia cells was mixed with the linearized DNA and the cell 
mixture was transferred to a 0.2 cm electroporation cuvette. The cuvette containing 
the cells was incubated on ice for 5 to 10 min, then, the electro-transfer was carried 
out using GenePulser (Bio-Rad) at 1.5 kV, capacitance of 25 µF and resistance of    
400 Ω, which generating pulse length of ~9.4 milliseconds with a field strength    
~1.37 kV/cm. Immediately thereafter, 1 ml of ice-cold 1 M sorbitol was added into 
the cuvette. The cells were flushed, spread onto a minimal dextrose medium          
(MD) agar plate, and grown at 30°C (took 2 to 3 days). 
 
 2.12  Purification of PCR product 
 
The DNA fragment amplified by PCR was purified using a QIAquick 
PCR Purification Kit (QIAGEN), following a protocol described by the company.     
In brief, 5 volumes of the binding buffer containing PCR product were added to the 
reaction mixture, and the entire mixture was applied onto a spin column. The 
impurities were washed out with a buffer containing ethanol. In final step, the DNA 
that bound to the column was eluted out with 30 to 50 µl of 10 mM Tris-HCl, pH 8.5 
and stored at -20°C. 
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 2.13  Purification of plasmid 
 2.13.1  by using the QIAprep Spin kit 
 
The E. coli plasmid was prepared by the alkaline lysis described by 
Birnboim and Doly (1979), using a QIAprep spin kit. An overnight culture of the 
plasmid was prepared in the presence of antibiotic (50 µg ampicillin/ml of culture). 
The bacterial cells were collected by centrifugation at 10,000 rpm for 15 s, and 
resuspended in 250 μl of 50 mM Tris-HCl containing 10 mM EDTA, pH 8.0 and 
RNase A. Then, the bacterial membrane was disrupted with 250 μl of a lysis buffer 
containing NaOH for 5 min at room temperature. The cell lysate was neutralized and 
adjusted with guanidine hydrochloride, a chaotropic salt, to a concentration of 1.6 M. 
Any precipitates of the bacterial chromosomal DNA and cell debris were removed by 
centrifugation at 14,000 rpm for 10 min. Then, plasmid in the supernatant was 
purified by absorption onto the surface of silica filter in a spin column. Bound 
plasmid was then separated from salts, proteins and other cellular impurities by 
washing with 750 μl of 20 mM NaCl and 2 mM Tris-HCl, pH 7.5 in 80% methanol. 
The plasmid was finally eluted with 50 μl of 10mM Tris-HCl, pH 8.5, and stored      
at -20oC until used.  
 
 2.13.2  by using the PCR purification kit 
 
A plasmid in an enzymatic reaction was purified with the same method 
described for purification of PCR product in section 2.12, using a QIAquick PCR 
Purification Kit (QIAGEN). 
 
 2.14  Purification of PCR product from agarose 
 
The DNA that was separated on agarose gel can be extracted and 
purified from gel by using the QIAquick Gel Extraction kit (QIAGEN). After analysis 
on 1% agarose containing 0.4 µg of ethidium bromide, gel band containing the DNA 
fragment of interest was excised with a sterile razor blade. The gel slice was then 
dissolved in a solution containing quanidine thiocyanate with the gel:solution ratio of 
1:3 (v/v). Thereafter, 1 gel volume of isopropanol was added, and all of the mixture 
was applied onto a QIA spin column. The DNA was adsorbed onto membrane in the 
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column while other impurities were washed out with 750 μl of a buffer containing 
ethanol. The purified DNA was eluted out from the column with 30 μl of                   
10 mM Tris-HCl, pH 8.5 and stored at -20oC until used. 
 
 2.15  Restriction analysis of DNA insert  
 
The chimeric TTR cDNA was constructed so that containing XhoI site 
at the 5′end and the EcoRI site at the 3′end of the molecule. The existence of the TTR 
cDNA in a plasmid, therefore, can be determined by double digestion of the plasmid 
with XhoI and EcoRI, and analysis the DNA insert by electrophoresis on                 
1% agarose gel containing 0.4 μg/ml of ethidium bromide. The double digestion was 
performed by incubating 4 μg of plasmid with 10 units of XhoI (Biolabs) and EcoRI 
(Biolabs) in 20 µl of the reaction volume, and the reaction mixture was incubated      
at 37oC for 2 h prior the analysis by electrophoresis was performed. 
 
 2.16  SDS-PAGE and non-denaturing PAGE 
 
Analysis of proteins under denaturing condition was carried out by  
sodium dodecyl sulfate polyacrylamide gel electrphoresis (SDS-PAGE) using        
12% polyacrylamide, pH 8.6 and 4% polyacrylamide, pH6.8 for resolving and 
stacking gels, respectively, with the discontinuous buffer system of Laemmli and 
Favre (1973). Protein samples were denatured by incubated with a solution 
containing SDS (69 mM) and β-mercaptoethanol (320 mM) at 100°C for 30 min prior 
the proteins were loaded onto the gel. After separation, the protein bands were 
detected by staining with silver nitrate (Morrissey, 1981) or Coomassie Brilliant blue 
R-250. 
The electrophoresis separation of proteins under non-denaturing 
conditions was performed similar to that performed for SDS-PAGE, except no SDS 
was added and 10% and 4% acrylamide were chose for resolving and stacking gels, 
respectively. The protein bands were detected by staining gel with Coomassie 
Brilliant blue R-250 or silver nitrate. 
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 2.17  Protein staining 
 
The protein on polyacylamide gel, after separation by electrophoresis 
under denaturing or non-denaturing condition, was detected either by Coomassie blue 
or silver nitrate.  
 
 2.17.1  by Coomassie blue staining 
 
After electrophoresis, gel was placed in a solution of 0.2% Coomassie 
brilliant blue R-250, dissolved in 50% methanol and 10% acetic acid, for 1 h. The 
excess dye was removed by rinsing the gel in a solution of 50% methanol and       
7.5% acetic acid until clear background was obtained. For storage, gel was kept in     
a solution of 5% methanol and 7.5% acetic acid. 
 
 2.17.2  by silver staining 
 
Gel staining with silver nitrate was performed by the method of 
Morrissey (1981). After electrophoresis, gel was placed in the solution of              
45% methanol and 10% acetic acid for 30 min and then transferred to the solution of 
7.5% acetic acid and 5% methanol for 30 min. Thereafter, gel was rinsed with 
distilled water for 3 to 4 changes prior to soaking in a solution of dithiothreitol (DTT) 
(500 µg/ml) for 30 min. The DTT solution was discarded and gel was soaked in    
0.1% silver nitrate for 20 min. To develop, gel was immersed in a solution of 3% (v/v) 
sodium carbonate and 0.02% (v/v) formaldehyde until protein bands appeared     
(took ~2-5 min depending on amount of proteins). To stop the reaction, the solution 
of   50% acetic acid was added until a few air bubbling occurred. Gel was washed 
several times with distilled water, and stored at 4oC. The protein pattern and band 
intensity were analyzed by gel document (with Labwork 4.0 program, Bio-Rad). 
 
 2.18  Determination of protein concentration 
 
Concentration of proteins was determined by the method of Bradford 
(1976). The reaction mixture comprised of 0.1 ml of protein sample and 1.0 ml of the 
assay reagent (0.085 mg/ml Coomassie blue G-250, 5% methanol, and 5.06% H3PO4). 
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The protein-dye complex was allowed to perform at room temperature for 2 min to 1h 
prior the optical density at 595 nm of the mixture was measured. The standard curve 
was generated using bovine serum albumin (BSA) at amounts of 0, 5, 10, 15, 20, and 
30 µg, and used to determine the protein concentration of the unknown proteins. 
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Table 1  Oligonucleotide primers used to generate cDNA for hu/croc/pigTTR 
 
PCR step Sequence 5′ → 3′ Direction 
1 
1,2 
2 
AACGGGCACTGGTGAATCCAAATGCC 
ACGGAATTCTCAAAGAGCTCCCTCCTTGGG 
CTCGAGAAAAGAGAGGCTGAAGCTGGCCCA
ACGGGCACTGG 
Sense 
Antisense 
Sense 
 
 
 
 
 
 
 
 43
CHAPTER 3 
 
 RESULTS AND DISCUSSIONS 
 
3.1 Construction of cDNA and cloning into expression vector for synthesis of 
the recombinant chimeric TTR in Pichia pastoris  
 
 
The primary structure of TTR subunit is well conserved among 
vertebrate species with the exception of the N-terminal region, which is located at the 
entrances to the central channel containing the thyroid hormone binding sites         
(for review see, Schreiber and Richardson, 1997). Since the last decades, TTRs from 
over 20 vertebrate species, including mammalian, avian, reptilian, and fish have been 
isolated and their amino acids or that derived from the cDNA clones were elucidated 
and compared (for reviews see Schreiber, 2002 and Richardson, 2007). The 
comparison revealed that the amino acid residues involved in the binding of TTR to 
thyroid hormones (Blake et al., 1978 and 1974) remained unchanged during evolution 
of the vertebrates. However, the most marked changes are concentrated in the N-
terminal region of the TTR subunit. The N-terminal segment of TTR is longer and 
more hydrophobic during evolution from avian, reptilian, amphibian and fish to 
mammalian (for review see Hamilton et al., 1993 and 2001). Similar variation also 
occurred at C-terminal region of TTR, leading to more hydrophobicity of the region 
in TTR from amphibian and fish than in mammalian. In addition, the C-terminal 
segments of TTRs from pig, Xenopus laevis and bullfrog are longer than other animal 
species. Due to the changes in length and hydrophathy occurred at N-terminal and    
C-terminal regions, and due to the fact that these N-terminus and C-terminus of TTR 
locate at the entrance to the thyroid hormone binding site, it prompted to an 
assumption that changes in structure of N-terminal segment and/or C-terminal 
segment of TTR subunit affect the accession of thyroid hormones as well as other 
ligands to the binding site of the TTR molecule. In order to elucidate roles of the     
N-and C-terminal regions on  biological function of TTR, a chimeric TTR in which its 
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N- and C-terminals segments are altered is most required. In this thesis, the 
recombinant hu/croc/pig TTR was thus constructed 
and its properties were examined. 
 
 
 The C. porosus TTR cDNA in pPIC9 vector was used as the template 
for PCR with the specific primer sets to generate the crocTTR having N-terminal 
sequence of human TTR and C-terminal sequence of pig TTR. By PCR, the 
recognition sequences for XhoI and EcoRI were also generated at 5′ and 3′ends, 
respectively, of the DNA to facilitate in ligation with the correct insertion direction of 
the DNA in pPIC9 expression vector. After PCR, the amplified DNA was purified 
and ligated to pGEM Teasy as described in section 2.2. The correct size of the DNA 
insert was determined by double digestion the DNA plasmid with XhoI and EcoRI as 
described in section 2.1. Analysis on 1% agarose gel, a single band of the DNA insert 
with size (∼400 bp) as expected for the hu/croc/pig TTR was detected (Figure 3.1) 
indicating correct direction of the insertion. The plasmid was transformed into E. coli 
strain DH5α to in vivo increase a number of the plasmid. To synthesize the 
hu/croc/pigTTR, P. pastoris strains GS115 was chose as a host and pPIC9 was 
selected as a carrier. The TTR gene was inserted into the pPIC9 at the multiple 
cloning sites, immediately after 3′end of the α-factor signal sequence (Figure 3.2). By 
nucleotide sequencing, it confirmed position and direction of insertion of the 
hu/croc/pig TTR gene in the pPIC9. To transform into Pichia cell, the recombinant 
pPIC9 was firstly linearized by SalI as described in section 2.3. By electroporation, 
from 103 to 104 cells of the Pichia transformants were obtained per microgram of the 
plasmid similarly to that previously reported (Scorer et al., 1994). Within the Pichia 
cell, the expression “cassette”, consisting of α-factor signal sequence and 
hu/croc/pigTTR gene was integrated into the yeast genome at the HIS4 gene locus. 
The expression of the hu/croc/pigTTR gene and secretion of the recombinant protein 
are mainly regulated by the AOX1 promotor.  
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Figure 3.1 Generation and amplification of hu/croc/pigTTR cDNA by 
 PCR  
The hu/croc/pigTTR cDNA was generated and amplified by PCR from 
the C. porosus TTR cDNA. The PCR product (1) was analyzed on       
1% agarose gel containing ethidium bromide along with the DNA 
markers (M). The DNA bands were visualized under UV. A single band 
of the hu/croc/pigTTR cDNA with 400 bp in size is indicated by arrow. 
 
  base pairs (bp) 
M               1 
100
 1000 
    500
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Figure 3.2   The Pichia expression vector pPIC9 for recombinant 
hu/croc/pigTTR 
  The cDNA of hu/croc/pigTTR was inserted into pPIC9 so that 
expression of the gene was under control of the AOX1 promoter and 
extracellular translocation and secretion was based on the α-factor signal 
sequence. Red, blue and green boxes are nucleotide sequences coding 
for N-terminal segment of human TTR, crocTTR without N-and          
C-termini and C-terminal segment of pig TTR, respectively. 5AOX1, 
promoter of P. pastoris alcohol oxidase 1 gene; 3(TT), native 
transcription termination and polyadenylation signal of alcohol oxidase 
1 gene; 3AOX, sequence from the alcohol oxidase 1 gene that locates    
3′ to the TT sequences; HIS4, histidinol dehydrogenase gene;            
Amp, ampicillin resistance gene, ColE1, E. coli origin of replication; 
SalI, the SalI restriction site for linearization of the vector.  
GlyAlaLeu*** 
GGAGCTCTTTGA 
CCTCGAGAAACT 
5'- TCGAGAAAAGAGAGGCTGAAGCTGGCCCTACG 
3'- AGCTCTTTTCTCTCCGACTTCGACCGGGATGC 
GlyProThr
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3.2  Screening for His+Mut+ transformant  
 
The pPIC9 expression vector containing the hu/croc/pigTTR cDNA 
was placed under the control of the native AOX1 promotor at XhoI and EcoRI sites. 
An expression of the AOX1 gene is controlled at the level of transcription. The 
inducer, methanol, is necessary for detectable levels of AOX1 expression (Ellis et al., 
1985; Koutz et al., 1989 and Tschopp et al., 1987a). However, losses of the AOX1 
gene leading to loss of ability in producing the alcohol oxidase and resulted in the 
methanol utilization slow (Muts) phenotype of the yeast. The MutS transformants 
cannot efficiently metabolize methanol as a carbon source therefore grow poorly on 
the minimal methanol (MM) medium. This slow growth when  methanol is used as 
the carbon source can be used to distinguish the His+ transformant in which the AOX1 
gene has been disrupted (His+ MutS) from the His+ transformant with an intact AOX1 
gene (His+Mut+). Up to 210 colonies of the hu/croc/pigTTR Pichia clones were 
screened for the His+Mut+ by comparing their growth on MM and MD plates as 
described in section 2.4. Growth pattern of the clones with His+Mut+ and His+Muts 
phenotypes is shown in Figure 3.3. Fifty two colonies of the putative His+Mut+ 
colonies were selected for the synthesis induction of recombinant hu/croc/pigTTR in 
small scale. 
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Figure 3.3 Selection for His+Mut+ transformants 
 The Pichia transformants with His+Mut+ or His+Muts phenotype were 
identified by comparing their growth on the MM and MD. His+Mut+ 
shows similar growth rate on both media, whereas, His+Muts has higher 
growth in MD than in MM. Close and broken circle indicate His+Mut+ 
and His+Muts phenotype, respectively. 
 
MD MM 
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3.3  Expression of hu/croc/pigTTR in Pichia pastoris 
 
P. pastoris has many advantages of eukaryotic expression systems 
such as protein processing, protein folding and posttranslational modification, while 
being easy to manipulate as E. coli or Saccharomyces cerevisiae. It is faster and 
easier to use and less expensive than other eukaryotic expression systems in particular 
the mammalian expression system. As a yeast, Pichia shares the advantages of 
molecular and genetic manipulations with Saccharomyces, however, provides          
10- to 100-fold higher expression, making the Pichia to be very useful as the 
production system of eukaryotic proteins (Grinna and Tschopp, 1989 and Tschopp   
et al., 1987b). P. pastoris is a methylotrophic yeast, capable of metabolizing 
methanol as its sole carbon source. In the first step of  the methanol metabolism, 
oxidation of methanol to formaldehyde using molecular oxygen is catalyzed by the 
enzyme alcohol oxidase. This reaction generates both formaldehyde and hydrogen 
peroxide. To avoid toxicity of the hydrogen peroxide, metabolism of methanol takes 
place within a special organelle called peroxisome, which sequesters the toxic by 
products from the rest of the cell. Alcohol oxidase has a poor affinity for O2, and       
P. pastoris compensates by generating large amounts of the enzyme. In the system of 
P. pastoris, high expression of the heterologous protein genes is regulated under the 
promoter of the alcohol oxidase (for review see Cregg et al., 2000). 
 
 3.3.1  Small scale synthesis  
 
In small scale synthesis of the hu/croc/pigTTR, a single colony of the 
Pichia clone on yeast extract peptone dextrose (YPD) was induced with                
0.5% methanol at 30oC for 3 days. Analysis of the culture supernatant by           
native-PAGE (10% and 4% of resolving and stacking gels, respectively) followed by 
silver staining showed that the chimeric TTR was successfully synthesized and 
extracellularly secreted into the culture medium (Figure 3A). A protein band with 
mobility similar to that of the TTR in human serum was observed. However, each 
Pichia recombinant clones provided different level of the expression (as shown in 
Figure 3.4A). The mobility of the recombinant chimeric TTRs was greater than 
albumin in human serum similarly to that previous reported for most TTRs from 
 50
vertebrates including human (Seibert and Nelson, 1942) and bird (Chang et al., 1999), 
which migrates faster than albumin during electrophoresis at pH 8.6 (Farer et al., 
1962 and Refetoff et al., 1970). Intensity of the TTR band obtained from each clone 
was measured by gel document to compare the production level. The result showed 
that the Pichia clone number 3 (as shown in Figure 3.4B) provided the highest 
production of the TTR. Therefore, this Pichia recombinant clone was selected for 
further optimization for synthesis of the recombinant TTR including methanol 
concentration and density of cells in the culture. 
 
 3.3.1.1  Optimization of the methanol concentration 
 
Growth of cell is very important for obtaining the secreted proteins 
because concentration of the protein product in medium is roughly proportional to the 
concentration of cell in culture. This is clearly observed when growing the P. pastoris 
in fermentation. In addition, the level of transcription initiated from the AOX1 
promoter can be 3-5 times greater in cell that is fed with methanol at growth-limiting 
rates compared to that grows in an excess methanol (Cereghino and Cregg, 2000). 
Therefore, optimization of growth and induction conditions including concentration 
of methanol and cell density is necessary and is one of the positive factors leading to 
the highest expression of recombinant protein.  
 
In optimizing, the Pichia clones were grown in 5 ml of BMGY at 
30°C overnight prior being transferred to BMMY and cells were induced with      
0.5% and 1% of methanol as described in section 2.5.1.1. Analysis of the culture 
supernatant by native-PAGE (10% resolving and 4% stacking gels) followed by silver 
staining revealed higher expression obtained when cells were fed with 1% methanol 
(Figure 3.5A). Intensity of the TTR produced from each clones was measured and 
analyzed by gel document and the result showed and confirmed that amount of the 
recombinant TTR obtaining when induced with 1% methanol was almost three times 
higher than when induced with 5% methanol (Figure 3.5B). Therefore, induction with 
1% methanol was chosen for scaling up the synthesis. 
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 3.3.1.2  Optimization of cell density in culture 
 
To explore for the suitable cell density, the induction with methanol 
was carried out at 1% of methanol with density of the Pichia cells in culture 
equivalent to 2 or 4 units of OD600. The induction was carried on for 3 days, and the 
culture supernatant was analyzed by native-PAGE. After staining gel with silver 
nitrate, a major protein band migrated with mobility corresponding to TTR was 
observed (Figure 3.6A). By analysis intensity of the TTR band from each Pichia 
clones with gel document, it revealed that production of the recombinant TTR 
increased from one to one and a half when density of cell in culture shifted from        
2 to 4 units of OD600 (Figure 3.6B). 
 
  3.3.2  Large scale expression of recombinant TTR  
 
To obtain large or sufficient amount of the recombinant chimeric TTR 
for further study, up scaling of the synthesis was attempted using the optimal 
conditions for the small scale synthesis in particular methanol concentration          
(1% methanol) and density of cell in culture (4 units of OD600). During the induction 
period, aliquot of the culture medium was collected every 24 h. Analysis of the 
culture supernatant by native-PAGE (10% resolving and 4% stacking gels) after the 
synthesis induction was carried on for 3 days was shown in Figure 3.7. On the        
native gel, the protein that migrated with mobility similar to TTR first appeared after 
the induction with methanol for 24 h (Figure 3.7A). Then, production of the TTR 
increased and reached maximum after induction for 3 days. Moreover, intensity of the 
TTR band was not changed after induction for 4 days, which was confirmed by 
analysis by gel document (Figure 3.7B). This revealed no degradation by proteases 
and indicated to high stability of the TTR in the culture medium similar to that 
previously reported for the recombinant TTR from other vertebrates i.e. Shrew 
(Prapunpoj et al., 2000a), X. laevis (Prapunpoj et al., 2000b) and C.  porosus 
(Prapunpoj et al., 2002). In average, production of the hu/croc/pigTTR by the 
expression system of Pichia was ~50 mg per liter of the 3 days culture, a little bit 
lower than that previously reported for TTRs from X. laevis (Prapunpoj et al., 2000b) 
and C. porosus (Prapunpoj et al., 2002). It should indicate to the possible variation 
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effect of nucleotide sequence of the gene, which is inserted into the expression 
cassette, on transcription and translation regulatory processes of the yeast.  
 
Amount of the recombinant protein synthesized and secreted by 
P. pastoris was highly depended on composition of the medium for growth. Several 
media were reported for successfully in expression of recombinant proteins in Pichia. 
The Pichia cell grew slower in minimal medium than in other complex media. The 
amounts of secreted proteins increased when the buffered medium was used        
(Clare et al., 1991). Therefore, to obtain the maximum production, growing and 
induction with methanol for synthesis of the recombinant TTRs were performed in 
the buffered medium i.e. BMGY and BMMY. The presence of substrates such as 
peptide components of the yeast extract and peptone was demonstrated reduces in 
action of the pH-dependent extracellular proteases in P. pastoris, which consequently 
decreases the proteolytic degradation of the secreted recombinant proteins           
(Clare et al., 1991). A time-course experiment for the production of the 
hu/croc/pigTTR showed that TTR was stable in the buffered medium throughout the 
induction period. 
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Figure 3.4 Synthesis of the recombinant hu/croc/pigTTR in small scale 
 
(A); The Pichia transformants were individually grown in BMMY and 
induced for synthesis with 0.5% methanol for 3 days. Thereafter, yeast 
cells were removed by centrifugation and aliquot (80 µl) of the culture 
supernatant was analyzed on native-PAGE (10% resolving and            
4% stacking gels). Protein bands were detected by silver staining.        
HS, human serum that overloaded to show positions of albumin (HSA) 
and TTR (TTR) in serum; 1 to 9, individual Pichia clone. Position 
corresponding to the hu/croc/pigTTR band is indicated by arrow.  
 (B); Arbitrary intensity measurement by gel document of the 
hu/croc/pigTTR produced from 52 individual recombinant Pichia clones.  
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Figure 3.5  Effect of methanol on production of the recombinant chimeric TTR 
  
 (A); The hu/croc/pigTTR clones were induced for synthesis with       
0.5% or 1% methanol for 3 days. Aliqout (100 μl) of the culture 
supernatant was analyzed by native-PAGE (10% resolving gel and      
4% stacking gels) and protein bands were detected by silver staining.   
HS, human serum that overloaded to show positions of albumin (HSA) 
and TTR (TTR); 1 to 8, the individual recombinant colonies of 
recombinant clone number 3. Position corresponding to the 
hu/croc/pigTTR band is indicated. 
 (B); Arbitrary intensity of the TTR produced by induction with 0.5% or 
1% methanol was measured by gel document. Data are the mean of three 
separate experiments. The error bars are the standard error of the mean 
between the experiments.  
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Figure 3.6 Effect of density of Pichia cells in culture on production of the 
 recombinant chimeric TTR 
  
 (A); The recombinant Pichia clone was grown and induced to synthesize 
TTR with the start density of the Pichia cells in culture equivalent         
to 2 and 4 units of OD600. Aliqout (80 μl) of culture supernatant was 
analyzed by native-PAGE (10% resolving and 4% stacking gels) and 
protein bands were detected by silver staining. HS, human serum that 
was overloaded to show positions of albumin (HSA) and TTR (TTR);    
1 to 8, the individual colonies recombinant clone number 3. Position 
corresponding to the hu/croc/pigTTR band is also indicated. 
(B); Arbitrary intensity of the hu/croc/pigTTR protein was measured by 
geldocument. Data are the mean of three separate experiments. The error 
bars are the standard error of the mean between the experiments. 
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Figure 3.7 Kinetic expression of the hu/croc/pigTTR 
  
 The Pichia transformant was induced with methanol for synthesis and 
secretion of the recombinant hu/croc/pigTTR expression for 4 days. The 
culture medium was daily sampling and aliquot (100 μl) of the culture 
supernatant was analyzed by native-PAGE. 
 (A); HS, human serum that overloaded to show positions of albumin 
(HSA) and TTR (TTR); 1 to 5 indicate day 0 to day 4 of induction with 
0.5% methanol. Position corresponding to the hu/croc/pigTTR band is 
indicated.  
 (B); Arbitrary intensity of the TTR was measured by gel document. 
Position corresponding to the hu/croc/pigTTR band is indicated.  
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3.4  Purification of the recombinant chimeric TTR  
 
In the Pichia expression system, the recombinant chimeric TTR was 
synthesized and secreted into medium, facilitating in downstream processing of the 
protein. Electrophoresis in a preparative polyacrylamide gel is useful technique for 
purification of the protein that migrates anodal ahead all other protein present. It is 
well known that most TTR from vertebrate species migrate anodal ahead other 
plasma proteins during non-denaturing polyacrylamide gel at pH 8.6 (Larsson et al., 
1985; Duan et al., 1995b and Prapunpoj et al., 2002). Analysis by native-PAGE of 
the Pichia culture supernatant showed that the expected protein band of the 
hu/croc/pigTTR produced by Pichia cells migrated preceding the albumin in human 
serum (Figure 3.4-3.7). Therefore, this method was chosen to purify the recombinant 
hu/croc/pigTTR from other endogenous protein of Pichia that co-secreted into the 
culture medium. 
 
The culture supernatant was concentrated prior loading onto the 
polyacrylamide gel tube. TTR in fractions can be determined by analysis on       
native-PAGE followed by silver staining of the protein band (Figure 3.8). As the 
recombinant chimeric TTR clearly migrated ahead other proteins, this facilitated in 
pooling out fractions containing the TTR. From several preparations, it showed that 
only ∼1 mg of the recombinant hu/croc/pigTTR can be purified per 1 liter of culture, 
which is much less than that previously reported for the recombinant crocTTR         
(16 mg per liter of yeast culture) (Prapunpoj et al., 2002). It suggested that low 
efficiency in the culture concentration step was the major factor leading to this 
extraordinary low purification yield. 
 
Facilitation in downstream processing of the recombinant protein of 
the P. pastoris expression system can be confirmed once in this thesis. The 
recombinant hu/croc/pigTTR that secreted out to the culture medium can be purified 
by the preparative native-PAGE. Although lower yield than expected was obtained 
but it is easy to perform and much less in time consuming as the purification of the 
TTR could be completed in only a single step. By other expression systems 
particularly of E. coli, several steps of purification including disruption the bacterial 
cell with some strong chemicals and detergents are required (Furuya et al., 1989; 
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Murrell et al., 1992; Berni et al., 1994; Steinrauf et al., 1993 and Rosen et al., 1994). 
Moreover, additional amino acid tags were needed to incorporate at N-terminus of 
TTR to facilitate in purification (Matsubara et al., 2003). 
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Figure 3.8 Analysis of the TTR eluting fraction from preparative native-PAGE 
The 3-days induction Pichia culture was analyzed by preparative    
native-PAGE (10% resolving and 4% stacking gels) using the PrepCell 
model 495. The protein fractions were eluted at flow rate 60 ml/h and 
collected at 2 ml per fraction. HS, human serum that overloaded to show 
positions of albumin (HSA) and TTR (TTR); 1 to 8, the individual 
fractions eluted from the preparative gel tube; C, the concentrated 
culture supernatant that loaded to show the position of the recombinant 
TTR. Position of the recombinant hu/croc/pigTTR is also indicated. 
hu/croc/pigTTRTTR 
HSA 
HS    1     2    3    4     5     6    7   8      C 
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Figure 3.9 Mobility of the hu/croc/pigTTR in native-PAGE 
 The purified hu/croc/pigTTR (1) was separated in native-PAGE       
(10% resolving and 4% stacking gels). The protein bands were 
visualized by silver staining. Human serum (HS) was overloaded to 
show the position of TTR (TTR) and albumin (HSA). 
TTR 
HSA 
      HS            1 
hu/croc/pig TTR 
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3.5  Purification of native TTR from human plasma 
 
Purification of native TTR from human plasma that use as a control 
for sufficient amount can be accomplished in 3 steps as described in section 2.9.  
 
In the first step, proteins in human plasma was separated by affinity 
chromatography on a Cibacon blue column. Unbound proteins including TTR were 
collected. The analysis of the unbound fraction by native-PAGE showed that 
although TTR can not be isolated out from most other proteins but most of albumin, 
which is the most abundant protein in plasma, can be removed out from the fraction 
(Figure 3.10). This was confirmed from major existence of albumin in the bound 
fraction that eluted out of the column with high salt (data not shown). In the second 
step, the fractions containing TTR were pooled and concentrated by ultrafiltration 
prior to purification was carried on based on typical mobility under native condition 
of the TTR. The concentrated pooled fraction was subjected to preparative         
native-PAGE prior to the eluting fractions were analyzed. The result shown that, 
within the step of preparative native-PAGE, the human TTR can be isolated from 
other proteins in the plasma (Figure 3.11), and it migrated to the similar position as 
TTR in human serum. It was reported that human TTR in plasma is always in bound 
form, particularly, with RBP (van Jaarsveld, 1973). Therefore, to obtain the TTR in a 
free form, the third step of purification was incorporated. The fractions containing 
TTR from the preparative native-PAGE step were pooled and concentrated prior to 
the electrophoresis separation was performed on urea gel. Analysis of the eluting 
fractions on native-PAGE and SDS-PAGE (Figure 3.12) followed by silver staining 
revealed no RBP was detected in the TTR containing fraction. The RBP was 
observed only in fraction of TTR before processing on the urea gel. This indicated 
that RBP can be completely removed out from the TTR-RBP complex. The TTR 
fractions were then pooled, concentrated and determined for concentration by 
Bradford method (Bradford, 1976).  
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Figure 3.10 Purification of native human TTR from plasma by Cibacon blue 
column chromatography 
 Human plasma was loaded into the Cibacon blue column at a flow rate 
of 10 ml/h. Fractions of unbound protein were collected and aliquot 
(30μl) of each fraction was analyzed by native-PAGE. The protein 
bands were detected by silver staining. HS, human serum that 
overloaded to show positions of albumin (HSA) and TTR (TTR); 1 to 9, 
an individual unbound fraction eluted from the Cibacon blue column. 
Arrow indicates position of the expected human TTR band. 
 HS    1     2      3      4     5      6     7      8    9 
HSA 
TTR 
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Figure 3.11 Elution pattern of native human TTR from the preparative native 
polyacrylamide gel 
 The concentrated pooled fraction containing human TTR from the 
chromatography on Cibacon blue column was applied onto a preparative 
native polyacrylamide gel (12% resolving and 4% stacking gels) and 
electrophoresis separation was performed using the Prep Cell model 491. 
Eluting fractions (2 ml/fraction) were collected, and aliquot (30 µl) of 
each fraction was analyzed by native-PAGE followed by silver staining. 
HS, human serum that was loaded to indicate TTR (TTR) and albumin 
(HSA) in serum; 1 to 9, the individual TTR containing fractions; arrow 
indicates the expected human TTR band. 
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Figure 3.12 Elution pattern of native human TTR from urea gel 
 Separation of  
 TTR from RBP was carried out on a preparative urea gel                  
(12% acrylamide resolving gel containing 6M urea). The concentrated 
pooled fraction containing TTR was loaded on the gel column and 
separation was conducted as described for the preparative native-PAGE. 
Aliquots (30 µl) of the eluting fractions from the urea gel were analyzed 
by native-PAGE (A) and SDS-PAGE (B), and protein bands were 
detected by silver staining. HS, human serum; HSA, albumin in human 
serum; TTR, native TTR in human serum; M, protein standard marker;  
1, TTR before the urea gel separation step; 2, TTR after applying onto 
the urea gel ; 1 to 12, the individual elution fractions. 
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3.6 Physicochemical properties of the recombinant TTR 
 
Most of eukaryotic proteins require some or all of modifications in 
cells for their biological function (Dube et al., 1988). These include processing of 
signal peptide, folding, and O- and N-linked glycosylation (Cereghino and Cregg, 
2000) of protein. Although the expression system of P. pastoris has capability in 
many post-translation modifications typically those presences in higher eukaryotes, 
the mechanism be hide the processing slightly differ from higher eukaryotes and 
possibly lead to alteration of properties and, thus, functions of the recombinant 
proteins. Therefore, physicochemical properties of the recombinant chimeric TTR 
including electrophoresis mobility under non-denaturing condition, molecular weight 
of molecule (indicates the tetramer forming), subunit mass and immuno-reactivity 
were determined. 
 
 3.6.1  Mobility in under non-denaturing condition 
 
The electrophoresis mobility of TTR in several vertebrates such as 
mammal, diprotodont marsupial and avain (Duan et al., 1995b and Chang et al., 1999) 
in non-denaturing polyacrylamide gel, at pH 8.6, was greater than that of albumin. 
Only in some eutherian such as pig, TTR co-migrated with albumin in the             
non-denaturing gel (Farer et al., 1962 and Refetoff et al., 1970). In comparison, 
mobility of the purified recombinant hu/croc/pigTTR synthesized in Pichia was faster 
than albumin in human serum (Figure 3.13). Moreover, it was also clearly faster than 
human TTR that purified from human (Figure 3.13, lane 2). Incidentally, this 
mobility was similar to that previously reported for the chimeric C. porosus TTR in 
which the N-terminal region of the TTR was replaced by that of human TTR 
(Prapunpoj et al., 2006), indicating that only the N-terminal segment but not the      
C-terminal segment affected on the mobility under native condition of the chimeric 
TTR. 
 
 
 
 71
 3.6.2  Molecular weight of the recombinant TTR 
 
Molecular weight of the recombinant hu/croc/pigTTR was determined 
by HPLC/gel-permeation chromatography on BioSil SEC 250 column (Bio-Rad) 
equilibrated in 0.2 M sodium phosphate buffer pH 6.0 as described in section 2.7.1. 
The proteins with known molecular weight i. e., chymotrypsinogen A (25 kDa), 
ovalbumin (43 kDa), bovine serum albumin (67 kDa), aldolase (158 kDa) and blue 
dextran (2,000 kDa) were used for calibration of the column. A standard curve was 
plotted between molecular weight in the logarithmic term (logMW) and Kav, which is 
calculated from the equation (Ve-Vo)/(Vt-Vo) where Ve is the elution volume of the 
protein, Vo is the exclusion volume of the column (equivalent to the elution volume 
of blue dextran 2000) and Vt is the total gel bead volume (equivalent to the elution 
volume of chymotrypsinogen A). The standard curve as shown in Figure 3.14 was 
used to determine the molecular weight of the recombinant chimeric TTR. 
Determination from the standard curve, molecular weight of the hu/croc/pigTTR 
tetramer was 58,884 daltons, which was similar to that reported for C. porosus TTR 
and it chimeric TTR (Prapunpoj et al., 2006), suggesting a proper tetramer forming of 
the recombinant chimeric TTR produced by Pichia. 
 
 3.6.3  Molecular mass of the subunit 
 
To determine mass of the subunit, an aliquot of the purified 
recombinant hu/croc/pigTTR was boiled for 30 min in presence of 2% SDS and   
2.5% β-mercaptoethanol, prior to performing SDS-PAGE (15% resolving and        
4% stacking gels) and protein band was detected by staining with Coomassie brilliant 
blue as described in section 2.7.2. Migration of the TTR was showed in Figure 3.15A. 
The molecular mass of the subunit calculated from the standard curve (Figure 3.15B), 
which plotted between the relative mobilities (Rf) of proteins and molecular weight in 
the logarithemic term (logMW), was 15,488 daltons, similarly to that previously 
reported for TTRs from other vertebrate species (Prapunpoj et al., 2002 and 
Richardson et al., 1994). This should demonstrate there was no modification, in 
particular glycosylation, occurred. 
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Figure 3.13 Mobility of purified recombinant hu/croc/pigTTR in native-PAGE 
 Purified recombinant hu/croc/pigTTR (1) and purified human TTR (2) 
were analyzed by native PAGE (10% resolving gel), and the protein 
band was stained by silver nitrate. HS is human serum. HSA and TTR 
are albumin and TTR detected in human serum, respectively. 
 
 
 
 
 
 
 
 
    HSA 
 TTR 
          HS         1          2 
 73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 Determination of molecular weight of the recombinant 
hu/croc/pigTTR 
Molecular weight of the TTR tetramer was determined by HPLC. The 
purified recombinant hu/croc/pig TTR (5 μg) was separated by gel 
filtration chromatography on Bio-Sil SEC 250 column at flow rate       
0.4 ml/min. The optical density of protein in fractions was measured at 
280 nm. The column was calibrated with proteins whose molecular 
weights are known including chymotrypsinogenA, (OVA; 43 kDa) 
albumin (ALB; 68 kDa), and aldolase (ALD; 158 kDa). A standard 
curve was plotted between Kav and log of molecular weight (log MW). 
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Figure 3.15 Determination of subunit mass of the recombinant hu/croc/pigTTR  
  
 (A) Purified recombinant hu/croc/pigTTR was boiled for 30 min in the 
presence of 2% SDS and 2.5% β-mercaptoethanol prior to analysis by 
SDS-PAGE (10% to 16% gradient resolving and 4% stacking gels) 
followed by staining with Coomassie brilliant blue. The molecular 
weight markers (M) are phosphorelase b (97.0 kDa), albumin (65.0 kDa), 
ovalbumin (45.0 kDa), carbonic anhydrase (30.0 kDa), trypsin inhibitor 
(20.1 kDa), and lysozyme (14.4 kDa). The TTR subunit mass was 
calculated from the Rf of the TTR monomer and compared it to those of 
the protein markers (1). 
 (B) Plot of the Rf against log of molecular weight (log MW) of the 
protein marker. 
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3.7  Western analysis  
 
The purified recombinant hu/croc/pigTTR (3 μg) and crocTTR (3 μg) 
(use as a control) were separated in duplicate on SDS-PAGE (15% resolving and      
4% stacking gels) and then transferred onto PVDF membrane. The TTR bands were 
detected with Coomassie brilliant blue and identified by the immuno-reactivity with 
antiserum. Non-specific binding was eliminated by blocking with the skim milk 
proteins. Antiserum against TTR purified from C. porosus, raised in rabbit, was used 
as the primary antibody (1:500). The excess antibody was removed with a buffer 
containing Tween 20 as described in section 2.10. The specific binding of the            
C. porosus TTR antibody to the recombinant chimeric TTR was enhanced for 
detection by using the horseradish peroxidase-linked anti-rabbit IgG as a secondary 
antibody. Two bands showing the immuno-reactivity were observed (Figure 3.16). 
The first protein band, with much higher intensity, migrated in the same position as 
the TTR monomer detected by Coomassie blue. The second band, with much low 
intensity, migrated slower and had a molecular mass ~30 kDa, consisting with a 
dimer of TTR that always found when denaturation of the protein is not complete 
even with harsh condition (Dickson et al., 1982; Furuya et al., 1989; Prapunpoj et al., 
2000b and 2002). This observation of the recombinant chimeric TTR dimer under the 
harsh denaturation should demonstrate to the strength of dimer-dimer interaction in 
the TTR. No the immuno-reactivity was detected in the protein markers, confirming 
the completion of the non-specific blocking.   
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Figure 3.16 Characterization of recombinant hu/croc/pigTTR  
The purified recombinant hu/croc/pigTTR (1) and crocTTR (2)             
(as a control) were analyzed by SDS-PAGE and the proteins were 
electrophoretically transferred onto a PVDF membrane. The protein 
bands were stained with Coomassie blue R (Coomassie) and identified 
with antiserum (Western). The membrane was incubated with            
anti-C. porosus TTR raised in rabbit (1:500) followed by                    
anti-(rabbit immunoglobulin) (1:2500) conjugated with horseradish-
peroxidase. Detection was carried out by the enzymatic reaction using 
DAB as substrate. The molecular weight markers (M) included were 
phosphorylase b (97.0 kDa), albumin (65.0 kDa), ovalbumin (45.0 kDa), 
carbonic anhydrase (30.0 kDa), trypsin inhibitor (20.1 kDa), and 
lysozyme (14.4 kDa). Position of the TTR monomer (monomer) and 
TTR dimer (dimer) are indicated. 
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3.8  Determination of the binding to RBP 
 
Another major function of TTR is binding to RBP, a single 
polypeptide chain with MW of 21 kDa that is responsible for the transport of the 
retinol (Monaco et al., 1995). Binding between TTR and RBP is thought prevents 
loss of the RBP from glomerular filtration in kidney (Nilsson and Peterson, 1971; 
Peterson and Rask, 1971; Kanai et al., 1968). Binding of TTR to RBP is specifically 
occurred at C-terminal region of the TTR (Monaco et al., 1995). In this thesis 
influence of N-and C-terminal regions of TTR on this property was studied. The 
binding between recombinant hu/croc/pig TTR to human RBP at difference molar 
ratio was investigated in comparison to that between the recombinant C. porosus TTR 
and human TTR. The binding reaction was carried out for 1 h at 4°C. Unbound TTR 
and that complexed with RBP were assessed. The results showed that changes in     
N- and C-terminal segments affected the complex formation of TTR with RBP 
(Figure 3.17). The complex forming between C. porosus TTR and RBP was detected 
from the molar ratio of 1:1 (Figure 3.17A), while that between the hu/croc/pigTTR 
was first detected at the molar ratio of 4:1, indicating that changes in either or both   
N- and C-termini decreased the formation rate of the complex. Chang in formation of 
the TTR-RBP complex was confirmed by the intensity plots of that unbound TTR and 
the complex with RBP (Figure 3.17), which revealed that the chimeric TTR bound to 
RBP at molar ratio of 7.5:1 (Figure 3.17D) while the C. porosus TTR bound to RBP 
at the molar ratio of 5:1 (Figure 3.17B). It was reported that the TTR-RBP complex is 
maintained through the hydrophobic interaction of the participated amino acid 
residues at the intermolecular contacts (Monaco et al., 1995). Therefore, longer and 
more hydrophilic of the hu/croc/pigTTR C-terminal region might be a major cause of 
less affinity in binding and, therefore, the binding rate of TTR to RBP as was 
observed in the experiment. Changes in length and hydropathy of the N-terminal 
region, on the other hand, may not directly effect on the binding between TTR and 
RBP. However, as it locates at the entrance to the central channel of the TTR 
molecular similarly to the C-terminal region, change in hydropathy environment due 
to change in amino acid sequence of the N-terminal region, may also effect on the 
hydrophobic interaction between hu/croc/pigTTR and RBP. However, the molar 
ratios of the dynamic binding observed in this thesis were higher than that previously 
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reported for the binding between human TTR and human RBP, which is 2:1 by X-ray 
crystallography (Monaco et al., 1995). Therefore, further experiments such as 
comparing the complex formation of other C. porosus TTR chimeric forms are 
required to confirm the postulation.  
 
 80
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
   TTR  RBP    1        2        3        4       5        6       7       8       9    
complex
TTR 
0
50000
100000
150000
200000
250000
300000
350000
1 2 3 4 5 6 7 8 9 10
Molar ratio of RBP:TTR
A
rb
ita
ry
 in
te
ns
ity
TTR
complex
B 
 81
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
complex 
 TTR  RBP  1      2        3       4      5      6        7       8        9 
C 
TTR 
0
20000
40000
60000
80000
100000
120000
1 2 3 4 5 6 7 8 9 10
Molar ratio of RBP:TTR
A
rb
ita
ry
 in
te
ns
ity
TTR
complex
D 
 82
Figure 3.17 Binding to RBP  
Purified recombinant C. porosus TTR or hu/croc/pigTTR was 
incubated with purified human RBP at molar ratio of RBP:TTR 
ranging from 1:1 to 9:1, at 4oC for 1h. Then, the reaction mixture was 
analyzed on native-PAGE (10% resolving and 4% stacking gels). The 
protein bands were transferred to nitrocellulose membrane and 
immuno-reactivity was detected using C. porosus TTR antibody   
(1:500) as the primary antibody and HRP-linked anti-rabbit IgG 
antibody (1:2,500) as the secondary antibody. Free TTR and TTR-RBP 
complex were detected by ECL. 
(A);  Protein band pattern of the C. porosus TTR and the complex 
with RBP, 1-9 indicate molar ratio of RBP:TTR ranging from 
1:1 to 9:1 
(B); Arbitrary intensity of the C. porosus TTR and the complex with 
 RBP (n=3) 
(C); Protein band pattern of the hu/croc/pigTTR and the complex 
 with RBP, 1-9 indicate molar ratio of RBP:TTR ranging from 
 1:1 to 9:1 
(D); Arbitrary intensity of the hu/croc/pigTTR and the complex with 
 RBP (n=3) 
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CHAPTER 4 
 
CONCLUSION 
 
1.  The cDNA for the chimeric hu/crco/pigTTR in which N- and C-terminal 
sequences of C. porosus TTR were replaced by the N- and C-terminal sequences 
of human TTR and pig TTR, respectively was successfully constructed in the 
pPIC9 expression vector of P. pastoris. The cDNA was expressed in P. pastoris 
and the chimeric TTR was synthesized and extracellularly secreted to culture 
medium. 
 
2. The optimal conditions for synthesis in P. pastoris of the recombinant          
hu/croc/pigTTR were induction with 1% methanol and P. pastoris cell density in 
culture equivalent to 4 units of OD600. At the optimal condition, the recombinant 
yeast produced ~50 mg of the chimeric TTR per liter of culture medium after 
induction with methanol for 3 days. 
 
3.  The recombinant chimeric TTR was purified by only a single step of  preparative 
 polyacrylamide gel electrophoresis under native condition with the purification 
 yield of 1 mg per liter of culture. 
 
4.  The recombinant chimeric TTR had the electrophoresis mobility under native 
 condition faster than albumin in human serum and the subunit mass determined 
 by SDS-PAGE was 15,488 daltons. 
 
5.  By gel permeation HPLC, the recombinant TTR tetramer showed the molecular 
 weight of 58,884 daltons. 
 
6.  By western analysis, the recombinant TTR had specific binding to the antibody 
 against C. porosus TTR. 
 
7.  In comparison to C. porosus TTR, the chimeric TTR showed higher molar ratio of 
 binding to RBP, suggesting the effect of changes in N- and C-terminal segments 
 of the TTR on this binding property.  
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